DrugPamphlet: Egyptian Drug Guide & Commentaries

Neonatal Herpes Simplex Virus (HSV): Interactive Clinical Study Tool

2026-11-11T13:17:00.384+00:00

Neonatal HSV Infection: Interactive Study Station

100% Source-Locked 2-Second Scan Lines Shortcuts: 1-7 Modes | D Dark Mode

📊 Mastery Progress: 0%

Cloze: 0/10 Cards: 0/12 Sorter: 0/12 Quiz: 0/10

Q1: Which virus types cause Neonatal HSV & when do symptoms appear? Agents & Timing

Causative Agents:Both HSV-1 and HSV-2 cause potentially life-threatening neonatal infection.
Global vs. UK Ratio:HSV-2 predominates in some global estimates, whereas recent UK surveillance shows a nearly equal distribution of HSV-1 and HSV-2.
Clinical Caution:HSV-1 is an important cause of neonatal disease and should not be overlooked.
Usual Onset Window:Symptoms usually develop during the first 4 weeks of life.
Late Presentation:Presentation may occasionally occur between 4 and 6 weeks of life.

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

نوع الفيروس: العدوى قد تحدث بسبب فيروس الهربس البسيط من النوع الأول (HSV-1) أو الثاني (HSV-2)؛ وفي بريطانيا النسبة بينهما متساوية تقريبًا لذا لا يجوز إهمال النوع الأول.
توقيت ظهور الأعراض: تظهر الأعراض عادةً في أول 4 أسابيع من عمر الرضيع، وقد تتأخر أحيانًا لتظهر بين الأسبوع الرابع والسادس.

Q2: How does the newborn acquire HSV & what makes risk highest? 3 Transmission Routes

1. Intrapartum (~85%):Most common route via exposure to infected maternal genital secretions during delivery.
Highest Risk Trigger:Maternal primary genital HSV infection near delivery → lacks sufficient protective antibodies to transfer to the infant.
2. Postnatal (Smaller %):Direct contact with individuals shedding HSV, especially active orolabial lesions (mothers, relatives, healthcare personnel).
3. Intrauterine (<5%):Rare congenital route → causes cutaneous lesions/scars, neurological abnormalities, and chorioretinitis.

SVG Visual: Transmission Breakdown

SVG Visual: Intrauterine (<5%) Congenital Findings

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

أثناء الولادة (85%): هي الطريقة الأشهر نتيجة التعرض لإفرازات الأم التناسلية المصابة، وتكون الخطورة في أقصى درجاتها إذا أصيبت الأم بالعدوى الأولية قرب الولادة لعدم وجود وقت كافٍ لتكوين أجسام مضادة تحمي الجنين.
بعد الولادة: بنسبة أقل، عبر التلامس المباشر مع قرح الفم والشفاه النشطة (الأم أو الأقارب أو الطاقم الطبي).
داخل الرحم (أقل من 5%): نادرة جدًا، وتسبب تشوهات خلقية تشمل ندبات أو آفات جلدية، واضطرابات عصبية، والتهاب المشيمية والشبكية.

Q3: How do the 3 clinical categories of Neonatal HSV present? Clinical Extent (Not Sequential Stages)

Core Principle:SEM, CNS, and Disseminated describe clinical extent of organ involvement and do NOT necessarily represent sequential stages.
1. SEM Disease:Limited strictly to skin, eyes, and/or mouth without CNS or visceral involvement; most localized with best prognosis when promptly treated.
SEM Cutaneous Signs:Grouped vesicles on an erythematous base (characteristic) → rupture into erosions, shallow ulcers, crusted lesions on scalp, face, trunk, extremities, or sites of skin trauma; healing may leave residual scarring or pigmentary changes.
SEM Eye & Mouth:Ocular: conjunctivitis, keratitis, less commonly chorioretinitis/retinal; Oral: vesicles, erosions, ulcers on oral mucosa, tongue, or lips.
2. CNS Disease:Brain involvement with or without skin lesions → lethargy, reduced activity, poor feeding, irritability, fever/temperature instability, focal or generalized seizures, abnormal muscle tone, altered consciousness, focal neuro signs.
CNS Neuroimaging:Produces multifocal or diffuse brain abnormalities (inflammation, edema, tissue injury); does not always follow typical adult temporal lobe pattern; early imaging can be normal.
3. Disseminated:Most severe form involving multiple organs, particularly liver and lungs (CNS may also occur) → sepsis-like illness, hepatitis/elevated ALT, coagulopathy/DIC, thrombocytopenia, pneumonitis/respiratory distress, encephalitis/seizures, shock, multiorgan dysfunction.
Diagnostic Red Flag:Cutaneous vesicles may be absent in a substantial proportion of CNS or Disseminated cases → always suspect HSV in unexplained sepsis, hepatitis, coagulopathy, or seizures even without skin rash.

💡 Memory Key — Disseminated HSV Target Organs & Crisis: "LIVER-LUNG-DIC" Liver (Hepatitis / high ALT) + Lungs (Pneumonitis / respiratory distress) + DIC (Coagulopathy & Thrombocytopenia) + Sepsis-like shock & CNS seizures — often with ZERO skin vesicles!

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

تصنيف مدى الإصابة: الأشكال الثلاثة (SEM و CNS والمنتشر) تصف مدى انتشار الفيروس في الأعضاء ولا تعني بالضرورة مراحل متتابعة يمر بها الطفل بالترتيب.
مرض الجلد والعين والفم (SEM): موضعي وأفضلها مآلاً؛ يتميز بحويصلات متجمعة على قاعدة حمراء قد تنفجر وتترك قرحًا سطحية أو قشورًا في مواضع إصابات الجلد.
مرض الجهاز العصبي (CNS) والمرض المنتشر (Disseminated): قد يحدثان بدون أي طفح جلدي إطلاقًا! المرض المنتشر يضرب الكبد والرئتين بقوة ويسبب حالة تشبه تسمم الدم واضطراب التجلط (DIC).

Q4: How do we confirm Neonatal HSV & avoid diagnostic traps? PCR & Workup Traps

Gold Standard Test:PCR testing is widely used and preferred for detecting HSV DNA (viral culture used in selected settings).
4 Key PCR Specimens:1) Vesicular lesion swabs, 2) Surface swabs (conjunctivae, mouth, nasopharynx, rectum), 3) CSF, 4) Blood (especially in suspected disseminated infection).
First 24h Swab Trap:Positive surface specimen within ≤24 hours after birth may reflect maternal contamination; specimens collected >24 hours identify active viral replication.
Early CSF Trap:Initially negative CSF PCR or normal CSF cell counts/biochemistry do NOT exclude early CNS HSV encephalitis → repeat CSF testing if suspicion remains high.
Serology Trap:Neonatal HSV serology is NOT useful: maternal IgG crosses the placenta and neonatal IgM has limited reliability.
Supportive Workup:CBC & platelets, LFTs (especially ALT), coagulation profile, renal function, brain MRI (for suspected CNS), EEG (seizures/encephalopathy), and ophthalmological exam.

💡 Memory Key — 4 Surface Swab Sites: "C-M-N-R" (Check Mucosa of Newborn Routinely) Conjunctivae • Mouth • Nasopharynx • Rectum (collect >24h after birth to prove active replication vs. maternal contamination).

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

فحص PCR هو الأساس: تؤخذ المسحات من البثور الجلدية، والمسحات السطحية (الملتحمة، الفم، البلعوم الأنفي، المستقيم)، والسائل النخاعي (CSF)، والدم.
ثلاثة فخاخ تشخيصية خطيرة: (1) المسحة السطحية الإيجابية خلال أول 24 ساعة قد تكون تلوثًا من إفرازات الأم وليست تكاثرًا فعليًا، (2) سلبية CSF PCR أو طبيعية خلايا السائل النخاعي في البداية لا تنفي التهاب الدماغ، (3) الأجسام المضادة (IgG/IgM) غير مفيدة تشخيصيًا.

Q5: What is the emergency treatment protocol, duration & prognosis? Medical Emergency

Emergency Rule:Start intravenous acyclovir promptly upon clinical suspicion without waiting for lab confirmation.
IV Acyclovir Dose:20 mg/kg/dose IV every 8 hours (assuming normal renal function; adjust intervals for gestational age, renal function, and clinical status).
IV Duration by Form:SEM disease = 14 days | CNS disease = at least 21 days | Disseminated disease = at least 21 days.
IV Safety Monitoring:Maintain adequate hydration and monitor renal function and blood counts during high-dose IV therapy.
End-of-Therapy Tap:In CNS disease, repeat CSF HSV PCR near/after day 21 → if HSV DNA remains detectable, continue IV acyclovir until viral clearance is documented.
Ocular Add-On:Ophthalmological assessment + topical ophthalmic antiviral (e.g., trifluridine 1%) in addition to systemic acyclovir.
Oral Suppression:Acyclovir 300 mg/m²/dose PO 3 times daily for 6 months after IV therapy; recommended for CNS disease (improves neurodevelopmental outcomes & reduces cutaneous recurrences).
Guideline Divergence:For Disseminated or SEM disease, guidelines vary: some recommend/consider oral suppression, while the strongest evidence for neurological benefit remains in CNS involvement.
Suppression Checks:Monitor CBC and renal function regularly and adjust dose as the infant grows.
Historical Mortality:Before effective antiviral therapy: ~85% died in Disseminated disease and 50% died in CNS disease (SEM had substantially better prognosis).
Long-Term Sequelae:Developmental delay, intellectual impairment, seizure disorders, motor impairment/abnormal tone, visual impairment, recurrent cutaneous lesions → requires long-term neurological, ophthalmological, and hearing follow-up.

SVG Visual: Acyclovir Treatment & CSF Clearance Timeline

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

العلاج الوريدي الطارئ: يُبدأ أسيكلوفير وريديًا فور الاشتباه بجرعة 20 ملجم/كجم كل 8 ساعات لمدة 14 يومًا لمرض SEM، و21 يومًا على الأقل لمرض CNS أو المنتشر، مع إعادة فحص السائل النخاعي عند نهاية علاج CNS للاستمرار حتى يختفي الفيروس تمامًا.
العلاج الوقائي الفموي واختلاف الإرشادات: يُعطى أسيكلوفير فمويًا (300 ملجم/م² ثلاث مرات يوميًا لمدة 6 أشهر) بعد العلاج الوريدي لمرضى CNS لتحسين التطور العصبي وتقليل انتكاس البثور الجلدية. أما في حالات SEM والمرض المنتشر فتختلف الإرشادات (بعضها يوصي به أو يدرسه، بينما يظل الدليل الأقوى للفائدة العصبية في حالات CNS).

De-Confuser 1: The 3 Clinical Forms Side-by-Side Word-Break Safe Table

Feature	SEM Disease	CNS Disease	Disseminated Disease
Organ Extent	Limited strictly to skin, eyes, and/or mouth (no CNS or visceral organs)	Brain involvement (with or without cutaneous lesions)	Multiple organs, especially liver & lungs (CNS may also occur)
Skin Vesicles	Characteristic grouped vesicles on erythematous base	May occur with or without cutaneous manifestations	May be absent in a substantial proportion of infants
Hallmark Signs	Vesicles, erosions, ulcers, conjunctivitis, keratitis	Lethargy, poor feeding, temperature instability, focal/generalized seizures	Sepsis-like illness, hepatitis (high ALT), DIC/coagulopathy, pneumonitis, shock
IV Acyclovir Duration	14 days	At least 21 days (+ repeat CSF PCR)	At least 21 days
Pre-Antiviral Mortality	Substantially better prognosis	~50% died historically	~85% died historically

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

هذا الجدول يفكك الالتباس الأشهر في الامتحانات: غياب البثور الجلدية لا ينفي مرض CNS أو المرض المنتشر، ومدة العلاج الوريدي 14 يومًا في SEM مقابل 21 يومًا على الأقل في CNS والمنتشر.

De-Confuser 2: Diagnostic Traps & Guideline Differences High-Yield Contrasts

Confusing Pair	Trap / Misconception	Source Reality (What to Do Instead)
Surface Swab ≤24h vs. >24h	Assuming a positive swab in the first 24 hours proves active neonatal infection	Swabs ≤24h may reflect maternal secretions contamination; swabs collected >24h identify established viral replication
Early Negative CSF vs. Rule-Out	Ruling out HSV encephalitis because initial CSF PCR or CSF cell count is normal	Early negative CSF PCR or normal CSF counts do NOT exclude early CNS disease → repeat CSF PCR if suspicion remains high
Neonatal IgG vs. IgM Serology	Ordering HSV serology to confirm acute neonatal infection	Not useful: maternal IgG crosses placenta; neonatal IgM has limited reliability
Adult vs. Neonatal Brain MRI	Expecting classic adult isolated temporal lobe lesions in every neonate	Neonatal HSV encephalitis may cause multifocal or diffuse abnormalities and early imaging can be normal
6-Month Oral Suppression Scope	Assuming all guidelines agree identically on SEM, CNS, and Disseminated suppression	Recommended for CNS disease (strongest neurodevelopmental trial evidence); guidelines vary for SEM and Disseminated

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

انتبه لفروق التوقيت: مسحة السطح قبل 24 ساعة = احتمال تلوث من الأم؛ بعد 24 ساعة = تكاثر فيروسي حقيقي. وكذلك رنين الدماغ في حديثي الولادة قد يكون متعدد البؤر أو منتشرًا ولا يشترط أن يقتصر على الفص الصدغي مثل البالغين.

Active Learning: Choose the Correct Term Inside Brackets [ a | b | c ]

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

اختر المصطلح الصحيح من بين الأقواس الثلاثة في كل سطر، ثم اضغط زر (Check My Answers) للتأكد من إجاباتك، أو زر (Highlight Correct) لتمييز الاختيارات الصحيحة مباشرة.

Adaptive Two-Sided Flashcards (1 / 12) Space = Flip | M = Mastered | L = Still Learning

FRONT — QUESTION (Click or press Space to flip)

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

اضغط على البطاقة لقلبها، ثم اختر (Mastered It) إذا حفظتها، أو (Still Learning) لتعود البطاقة إليك مرة أخرى حتى تتقن جميع البطاقات.

Clinical Categorization Sorter: Place Each Item in Its Correct Group

Clinical Finding / Rule to Classify (1 / 12):

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

اقرأ العلامة السريرية أو القاعدة العلاجية في المربع العلوي، ثم اضغط على المجموعة الصحيحة من المجموعات الأربع بالأسفل لتحصل على تنبيه فوري بالصواب أو الخطأ.

Part A: Rapid Numbers, Doses & Time-Cutoffs Drill

Part B: Diagnostic & Clinical Reasoning MCQ (Score: 0 / 10)

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

الجزء الأول يختبر أخطر الأرقام والجرعات التي تُنسى في الامتحان، والجزء الثاني اختبار اختيار من متعدد يظهر لك التفسير العلمي فور الإجابة ويتيح لك إعادة الأسئلة الخاطئة فقط.

Exam-Eve Ultra-Condensed Bare Keywords Sheet 60-Second Final Scan

Agents: HSV-1 & HSV-2 (UK: ~equal ratio; Global: HSV-2 larger share).

Onset: Usually first 4 weeks (occasionally 4–6 weeks).

Intrapartum: ~85%; peak risk = maternal primary genital HSV near delivery (no antibody transfer).

Postnatal: Direct contact → active orolabial lesions (mother, family, staff).

Intrauterine: <5% → congenital skin lesions/scars, neuro abnormalities, chorioretinitis.

SEM Form: Skin/Eye/Mouth only; grouped vesicles on erythematous base; best prognosis; 14d IV.

CNS Form: Lethargy, seizures, temp instability; ± skin vesicles; multifocal/diffuse MRI; ≥21d IV.

Disseminated Form: Liver (ALT) + Lungs + DIC + shock; vesicles often absent; ≥21d IV.

PCR Swabs (>24h): Vesicles + Conjunctivae, Mouth, Nasopharynx, Rectum (≤24h = maternal contamination).

CSF & Serology Rules: Early negative CSF PCR does NOT exclude CNS HSV; Serology (IgG/IgM) not useful.

Acute Regimen: IV Acyclovir 20 mg/kg q8h immediately on suspicion; repeat CSF PCR at day 21 in CNS.

Ocular & Oral Suppression: Topical trifluridine 1% + Oral acyclovir 300 mg/m² PO TID x 6 mo (CNS proven benefit; SEM/Diss guidelines vary).

إضافة مساعدة للشرح (ليست نصًا حرفيًا من المصدر)

هذه البطاقات الاثنتا عشرة تلخص كامل المحاضرة في كلمات مفتاحية مجردة لمراجعة ليلة الامتحان في دقيقة واحدة.

Consolidated Source References (Listed Once with Publication/Update Dates):

Allen UD, Robinson JL, Bitnun A, McDonald J. Prevention and management of neonatal herpes simplex virus infections. Canadian Paediatric Society. Updated October 10, 2025; reaffirmed January 12, 2026.
Clarke E, Patel R, Dickins D, et al. Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update). Int J STD AIDS. 2025;36(1):4–23. doi:10.1177/09564624241280734.
American Academy of Pediatrics. Herpes simplex virus. In: Red Book: 2024–2027 Report of the Committee on Infectious Diseases. 33rd ed. American Academy of Pediatrics; 2024.
Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230–238. doi:10.1542/peds.108.2.230.
Kimberlin DW, Whitley RJ, Wan W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284–1292. doi:10.1056/NEJMoa1003509.

Congenital Cytomegalovirus (CMV): Interactive Clinical Study Tool

2026-11-11T03:09:19.016+00:00

Active recall · Source-based · Offline

Congenital CMV

Skin clues → diagnosis → treatment → follow-up

Cutis Marmorata Telangiectatica Congenita (CMTC): Interactive Clinical Study Tool

2026-11-07T00:40:22.839+00:00

CMTC — Interactive Study Tool

Interactive study tool

Cutis Marmorata Telangiectatica Congenita CMTC

Organised by the questions you will actually be asked. Highlighted words = what to remember first.

What is CMTC?

TypeRare congenital vascular anomaly, generally classified as a capillary malformation

HallmarkPersistent reticulated (net-like) discoloration: erythematous, bluish or violaceous

LookCharacteristic marbled appearance from abnormal cutaneous vasculature

May also showTelangiectasia · cutaneous atrophy · ulceration (less common)

OnsetEvident at birth or shortly afterward

ExtentA localized region, or less commonly more extensive areas

NatureGenerally benign, but some children need evaluation for skin changes, limb asymmetry or eye problems

Decode the name

CutisSkin

MarmorataMarbled

TelangiectaticaDilated small vessels

CongenitaPresent at birth

شرح مساعد بالعربية — ليس من المصدر

• تشوّه خلقي نادر في الشعيرات الدموية بالجلد.

• يظهر كشبكة لونها أحمر أو أزرق أو بنفسجي، موجودة منذ الولادة ولا تزول.

• غالبًا حميد، لكنه قد يحتاج متابعة للجلد والأطراف والعين.

Normal newborn mottling or CMTC?

Physiological cutis marmorataCMTC

WhenAppears / more noticeable when coldPresent at birth or shortly after

WarmingDisappears or almost completely resolvesPersists; intensity may vary

WhereRelatively broad areasOften localized, segmental, asymmetric

Skin changesNo persistent atrophy, ulceration or limb asymmetryMay show telangiectasia, atrophy, ulceration

WhyTemporary blood-flow changes in superficial vesselsAbnormal cutaneous vasculature

The warming response: before / after

Warming = useful clue, NOT a definitive test.
Diagnose on the overall clinical appearance and examination.

Memory key

P = Passing · C = Constant
Physiological passes with warmth; CMTC stays.

شرح مساعد بالعربية — ليس من المصدر

• التبقّع الطبيعي عند حديثي الولادة يظهر مع البرد ويختفي بالتدفئة.

• أما CMTC فيبقى رغم التدفئة، وغالبًا يكون في جهة واحدة أو منطقة محددة.

• اختبار التدفئة مجرد دليل مساعد، وليس اختبارًا حاسمًا.

What does CMTC look like?

1 · PatternPersistent net-like reddish-purple, bluish, violaceous discoloration

Gets stronger withCold · crying · fever · temperature / blood-flow changes. Variable, not in every patient

2 · DistributionLocalized, segmental or generalized

SymmetryAsymmetric is common, but bilateral and generalized are reported

3 · AtrophySkin thinning: depressed, shiny, unusually thin

4 · TelangiectasiaSmall visible dilated vessels, especially in persistent lesions

5 · UlcerationImportant but less common; in areas of more severe vascular involvement; may need specialized wound care

Where CMTC appears

Lower limbs: frequently affected, may be extensive

Upper limbs: alone or with other regions

Trunk: in localized or generalized forms

Face & scalp: less commonly involved

Memory key

Skin falls like paint: heaviest at the bottom (legs), lightest at the top (face).

شرح مساعد بالعربية — ليس من المصدر

• الشبكة الملوّنة قد تزيد مع البرد أو البكاء أو الحمّى، لكن ليس عند كل الأطفال.

• الساقان أكثر الأماكن إصابة، والوجه وفروة الرأس أقلها.

• قد يرقّ الجلد ويلمع، وقد تظهر أوعية دقيقة، ونادرًا تقرّحات.

What causes CMTC?

Exact causeNot fully understood

Most casesSporadic: no known family history or inherited pattern

Gene foundSomatic mosaic variants in GNA11, in some individuals

Mosaic meansArise during development; affect only a proportion of cells, which may explain why only some skin areas are affected

LimitsGNA11 is not found in all patients; the basis of many cases remains unknown

PregnancyNo established evidence linking it to a maternal behavior or routine exposure

Mosaic cells (dark), then a patchy, segmental skin pattern

Memory key

Mosaic cells → mosaic skin.
Only the cells carrying the change make the marbled patch.

شرح مساعد بالعربية — ليس من المصدر

• السبب الدقيق غير معروف، ومعظم الحالات بلا تاريخ عائلي.

• عند بعض المرضى وُجد تغيّر في جين GNA11 في جزء من خلايا الجسم فقط (فسيفسائي).

• لا دليل ثابتًا على أن الأم تسببت فيه بسلوك أو تعرّض أثناء الحمل.

What else should we look for?

Limbs

FindingsHypotrophy (smaller) or hypertrophy (larger) · leg-length discrepancy · circumference differences · weakness / altered function

Key factDirection and degree vary, so take periodic measurements during growth

Eyes

ReportedEarly-onset glaucoma · peripheral retinal vascular abnormalities (retinal nonperfusion, neovascularization)

ActionComprehensive eye exam after diagnosis: intraocular pressure + retina

WhoNot only facial lesions. Don't skip because lesions are elsewhere

How oftenDecided by the ophthalmologist, based on findings and needs

Neurological & other

NeuroSeizures, developmental delay: occasionally reported, not characteristic of isolated CMTC, so consider other diagnoses

OtherOther vascular / congenital anomalies described; absent in most

SkinAtrophy, telangiectasia, ulceration affect wound care and long-term skin monitoring

Don't mix up

Hypotrophy = under-grown, smaller limb

Hypertrophy = over-grown, larger limb

Memory key

Two body checks: L + E = Limbs (tape measure) + Eyes (Glaucoma pressure + Retina)

شرح مساعد بالعربية — ليس من المصدر

• الطرف المصاب قد يكون أصغر أو أكبر من الآخر، لذلك يُقاس دوريًا.

• فحص العين ضروري لكل طفل بعد التشخيص، حتى لو كانت البقع في الساق.

• التشنجات وتأخر النمو ليست من صفات CMTC المعزول، ووجودها يستدعي البحث عن تشخيص آخر.

How is CMTC diagnosed?

BasisPrimarily a clinical diagnosis

ExamineDistribution & extent · persistence after warming · telangiectasia / atrophy · ulceration · limb length & circumference · eye / systemic

HistoryOnset of skin changes + family history

Proposed clinical criteria

Major (3)Minor (6)

ListCongenital reticulated erythema
Persistence despite warming
Absence of venectasiaTelangiectasia · fading of erythema over time · cutaneous atrophy · ulceration · port-wine stains · body asymmetry

Memory key

Major = CPA (Congenital, Persistence, Absence of venectasia)
Minor = TEA PUB (Telangiectasia, Erythema fading, Atrophy, Port-wine, Ulceration, Body asymmetry)
The CPA meets you in the TEA PUB.

Two views

Criteria sayAbsence of venectasia is a major criterion

ButVenectasia has been documented in a proportion of patients, so its absence is not an absolute requirement

ResultCriteria are not universally definitive; use the overall picture and exclude mimics

Tests: who gets what

Eye examImportant: IOP · anterior segment · dilated fundus · peripheral retinal vascular imaging when indicated

ImagingNot routine in typical isolated CMTC; consider if limb / neuro / vascular / structural findings

Genetic testNot routine; selected patients (suspected broader mosaic disorder or other genetic condition)

Negative GNA11Does not exclude a clinical diagnosis

Skin biopsyGenerally unnecessary; histopathology not specific enough alone

Don't mix up

Telangiectasia: may be present, a minor criterion

Venectasia: its absence is a proposed major criterion

Memory key

No routine I·G·B (Imaging, Genetics, Biopsy). The eye exam is the test everyone gets.

شرح مساعد بالعربية — ليس من المصدر

• التشخيص بالفحص السريري أساسًا.

• المعايير الكبرى ثلاثة والصغرى ستة، لكنها ليست قاطعة.

• بعض المرضى عندهم venectasia رغم أن غيابها معيار كبير، وهذا رأيان مختلفان.

• الأشعة والتحليل الجيني والخزعة ليست روتينية، وتحليل جيني سلبي لا ينفي المرض.

What else could it be?

Physiological CMTemporary, cold-induced; resolves or almost disappears with warming

Livedo reticularisReticulated pattern in various clinical settings; tell apart by distribution, persistence, associated findings

Other capillary malformationsMay look reticulated or lace-like and resemble CMTC

Port-wine stain(Nevus flammeus) persistent flat patch, pink-to-red or violaceous, not net-like

Overgrowth / vascular syndromesKlippel–Trenaunay · Sturge–Weber · PIK3CA-related overgrowth

Don't mix up

CMTC = a NET (reticulated lines)

Port-wine stain = a PATCH (flat, filled-in colour)

شرح مساعد بالعربية — ليس من المصدر

• أهم ما يُخلط به: التبقّع الطبيعي (يزول بالتدفئة) والوحمة النبيذية (بقعة مسطّحة ممتلئة اللون، لا شبكة).

• هناك متلازمات وعائية تشبهه وتحتاج تفريقًا: Klippel–Trenaunay وSturge–Weber والمتعلقة بـ PIK3CA.

How is CMTC managed?

Core ruleNo established curative treatment; management is supportive and directed at complications

Observation

DiscolorationMany children need no active treatment

Follow-upPattern changes · atrophy / ulceration · limb length & circumference · pain, weakness, temperature sensitivity · new abnormalities

Until whenLimb involvement: monitor until skeletal maturity

Wound care (if ulcer)

StepsGentle cleansing · non-adherent protective dressings · suitable moist environment · watch for infection · specialist if persistent / extensive

AntibioticsTopical antibiotics not routine; only when indicated (suspected / confirmed secondary bacterial infection)

Memory key

Clean · Cover · Moist · Watch · Refer

Laser

OptionsPulsed Dye Laser (PDL) and selected other vascular lasers

RealityFor cosmetic concerns. Response varies; complete clearance not guaranteed; evidence limited; decided individually after specialist assessment

Precautions

ColdAvoid excessive cold if it causes discomfort

NeedlesAvoid blood draws / IV cannulation in an affected limb when an alternative exists, because of vascular fragility

SkinWatch for early signs of ulceration

Associated problems

ReferralsOphthalmology (glaucoma, retina) · Orthopedics (limb-length / growth) · wound care (persistent ulcers)

شرح مساعد بالعربية — ليس من المصدر

• لا علاج شافٍ، والعلاج داعم للمضاعفات فقط.

• التقرّح يُعالج بتنظيف لطيف وضمادة لا تلتصق وبيئة رطبة، والمضاد الحيوي فقط عند العدوى.

• الليزر قد يحسّن الشكل لكنه لا يضمن الإزالة الكاملة.

• تجنّب سحب الدم من الطرف المصاب إن أمكن.

What is the long-term outlook?

OverallGenerally favorable, especially with isolated skin involvement

ImprovementMore than half may show some fading over time

WhenCan begin in infancy; rate and extent vary

Not always goneComplete disappearance not expected in every patient; residual telangiectasia, discoloration or atrophy may remain

Depends onAssociated problems: limb asymmetry, ocular complications

BirthPattern present at birth or shortly after

After diagnosisEye exam: IOP + retina

InfancyFading may begin

Growth yearsPeriodic limb length & circumference

Skeletal maturityLimb monitoring generally continues until here

شرح مساعد بالعربية — ليس من المصدر

• المآل جيد غالبًا، وأكثر من نصف الحالات تبهت مع الوقت.

• قد يبقى أثر خفيف، والمتابعة المبكرة تكشف المضاعفات.

Sources

1. Tamburro J, Traboulsi EI, Patel MS. Isolated and Classic Cutis Marmorata Telangiectatica Congenita. GeneReviews®. Initial publication 9 June 2022. https://www.ncbi.nlm.nih.gov/books/NBK581081/

2. Bui TNPT, Corap A, Bygum A. Cutis marmorata telangiectatica congenita: a literature review. Orphanet J Rare Dis. 2019;14:283. https://doi.org/10.1186/s13023-019-1229-8

3. Kienast AK, Höger PH. CMTC: a prospective study of 27 cases and review of the literature. Pediatr Dermatol. 2009;26(5):518–522. https://pubmed.ncbi.nlm.nih.gov/19840319/

4. Kamholtz I, Gaumond SI, Schachner LA, et al. Clinical presentation, risk factors, and comorbidities of CMTC: a systematic review. Pediatr Res. 2026;100:120–125 (online 9 Dec 2025). https://doi.org/10.1038/s41390-025-04588-8

5. DermNet. Cutis marmorata telangiectatica congenita. https://dermnetnz.org/topics/cutis-marmorata-telangiectatica-congenita

Educational use only; not a substitute for professional medical assessment. Study tool built November 2026 from the supplied source text.

Aplasia Cutis Congenita (ACC): Interactive Clinical Study Tool

2026-11-06T23:32:14.835+00:00

Mastery Progress: 0%

Shortcuts: 1–8 Modes | Space Flip

Q1: What is Aplasia Cutis Congenita (ACC) & What tissue layers can be missing?

Definition & Depth

Core Defect:Rare congenital localized (or rarely widespread) absence of skin at birth.
Mild Depth:Involves the epidermis alone or extends through the dermis.
Severe Depth:Extends into subcutaneous tissue and exposes periosteum, skull, or rarely dura mater.
Primary Site:Most commonly the scalp (particularly vertex and midline); also face, trunk, and extremities.
Clinical Priority:Often isolated, but MUST screen for underlying structural defects, genetic disorders, or syndromes.

Visual 1: ACC Depth Spectrum (Epidermis → Dura Mater)

Visual 2: Hair Collar Sign & Topographical Syndrome Map

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

التعريف ببساطة: يولد الطفل ببقعة ينقصها الجلد (غالبًا في قمة الرأس Vertex).
تدرج العمق: قد يكون النقص سطحيًا (البشرة فقط) أو عميقًا يصل للأدمة والنسيج تحت الجلد، وفي الحالات الشديدة يكشف السمحاق أو عظم الجمجمة أو حتى الأم الجافية (Dura mater).

Q2: How common is ACC & Why do published incidence numbers differ?

Epidemiology & Conflict Note

Estimate 1 (Clinical):Clinical references commonly cite 1–3 cases per 10,000 live births (equals 10–30 per 100,000).
Estimate 2 (European):Large European population-based study reported 5.1 per 100,000 births (shows variability in published estimates).
Inheritance Pattern:Most nonsyndromic cases are sporadic; familial cases show autosomal dominant or autosomal recessive inheritance.
Timing of Detection:Usually recognized at birth; lesions healed in utero present as congenital scars or scarring alopecia.

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

انتبه لاختلاف الأرقام في المصادر: المراجع السريرية تذكر (1 إلى 3 لكل 10,000 ولادة حية)، بينما دراسة أوروبية سكانية كبرى سجلت (5.1 لكل 100,000 ولادة). كلا الرقمين مهم للامتحان كمثال على تفاوت التقديرات المنشورة.
الوراثة والظهور: أغلب الحالات غير المتلازمية فردية (Sporadic)، وقد يلتئم الجرح داخل الرحم فيولد الطفل بندبة جاهزة خالية من الشعر.

Q3: What causes ACC in utero? (6 Proposed Mechanisms)

Etiology & Pathogenesis

Core Dual Mechanism:Either impaired skin development during embryogenesis OR intrauterine destruction of already formed skin.
1. Genetic Factors:Pathogenic variants in genes governing skin development, vascular formation, and embryonic morphogenesis.
2. Vascular Disruption:Intrauterine vascular compromise, placental infarction, and fetal ischemic events.
3. Mechanical Factors:Amniotic band-related disruption, abnormal intrauterine tension, and mechanical trauma.
4. Teratogenic Drugs:Maternal methimazole, carbimazole (antithyroid drugs), valproate, and misoprostol.
5. Intrauterine Infections:Congenital varicella and herpes simplex virus (HSV) infections.
6. Co-Twin / Placenta:Placental infarction or intrauterine death of a co-twin (fetus papyraceus).

💡 Memory Key — 4 Teratogens ("M-C-V-M"): Methimazole + Carbimazole (Thyroid pair) & Valproate + Misoprostol.

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

الآلية الأساسية: إما أن الجلد لم يتكون أصلًا أثناء التخلق الجنيني، أو تكوّن ثم تدمّر داخل الرحم (بسبب نقص تروية، أشرطة أمنيوسية، عدوى جدري الماء/الهربس، وفاة التوأم Fetus papyraceus، أو أدوية الأم مثل الميثيمازول والكاربيمازول والفالبروات والميزوبروستول).

Q4: How does ACC look clinically & What red-flag signs matter?

Clinical Features

Morphology Range:Well-demarcated erosion/ulcer (raw/granulating base), translucent membrane, or healed atrophic scar lacking skin appendages.
Hair Collar Sign:Ring of longer or darker hair surrounding a scalp defect → warns of underlying cranial or neural tube abnormality.
Membranous ACC:Thin, shiny, translucent covering; on the scalp, signals possible underlying skull defects or structural anomalies.
Extremity Pattern:Arms/legs involved in isolation or syndromes; often bilateral and symmetrical when associated with epidermolysis bullosa.

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

علامة طوق الشعر (Hair Collar Sign): حلقة من شعر أطول أو أغمق تحيط بآفة فروة الرأس؛ هي جرس إنذار لاحتمال وجود تشوه في الجمجمة أو الأنبوب العصبي تحتها.
النوع الغشائي (Membranous): يكون مغطى بغشاء رقيق لامع شفاف بدلًا من قرحة مفتوحة، وفي الرأس قد يخفي تحته عيبًا عظميًا في الجمجمة.

Q5: When is imaging required & When is biopsy forbidden?

Diagnosis & Safety Rules

Primary Diagnosis:Primarily clinical + full exam (limbs, nails, CMTC, neuro/cardiac) + maternal history (drugs, infections).
5 Imaging Triggers:(1) Size > 4 cm, (2) Hair collar sign/tufting, (3) Suspicious midline vertex, (4) Membranous/hemorrhagic lesion, (5) Neurological signs.
Imaging Modalities:Ultrasound (initial soft tissue/skull/vascular check) → MRI (detailed intracranial structures) → CT (detailed bony defect, mind radiation).
Biopsy Safety Rule:Routine biopsy NOT needed; NEVER biopsy or excise a suspicious scalp lesion before excluding intracranial/vascular connections by imaging.
Histopathology:Absent/thinned epidermis and dermis, reduced/absent skin appendages, and increased vascularity.

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

قاعدة الأمان الذهبية: إياك وأخذ خزعة (Biopsy) أو تدخل جراحي في آفة فروة رأس مريبة قبل إجراء التصوير لاستبعاد اتصالها بالأوعية الدموية أو الدماغ.
دواعي التصوير الخمسة: حجم أكبر من 4 سم، وجود علامة طوق الشعر، موقع قمة الرأس الناصف المريب، آفة غشائية أو نازفة، أو وجود أعراض عصبية.

Q6: Conservative vs. Surgical Care & What is the Prognosis?

Management & Prognosis

Conservative Care:For small, superficial, uncomplicated defects: gentle cleansing, moist/non-adherent dressings, infection/bleeding watch.
Newborn Warning:Caution with topical silver sulfadiazine in newborns due to risk of systemic absorption.
Surgical Triggers:Large/deep defects with exposed dura, major skull involvement, or high risk of hemorrhage/infection.
Surgical Options:Primary closure, skin grafting, local/regional flaps (via multidisciplinary team: peds derm, plastics, neurosurgery).
Prognosis:Small isolated lesions heal in weeks to months (excellent prognosis, leaves atrophic scar / alopecia); deep/syndromic cases depend on systemic/intracranial severity.

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

العلاج التحفظي مقابل الجراحي: الآفات الصغيرة السطحية تلتئم تلقائيًا خلال أسابيع لأشهر بضمادات رطبة غير لاصقة (مع الحذر من كريم سلفاديازين الفضة Silver sulfadiazine لخطر امتصاصه جهازيًا في حديثي الولادة). الجراحة تُخصص للعيوب الكبيرة أو عند انكشاف الأم الجافية وخوف النزف والعدوى.

Active Cloze Recall — Select the Correct Bracketed Term, Then Verify

Checked: 0 / 10

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

اختر المصطلح الصحيح من بين الاختيارات الثلاثة داخل الأقواس في كل سطر، ثم اضغط زر Verify My Choices لتثبيت الحفظ النشط.

1. The 3 Major ACC Syndromes — Side-by-Side De-angler

High-Yield Comparison

Feature	Bart Syndrome (Frieden Type VI)	Adams–Oliver Syndrome (Frieden Type II)	Setleis Syndrome (FFDD3)
Preferred / Alt Name	EB with congenital absence of skin	Scalp ACC + Terminal limb defects	Bitemporal forceps marks syndrome
Classic ACC Site	Lower extremities (bilateral/symmetrical legs)	Scalp vertex (± underlying skull defect)	Bilateral temporal face (forceps-like)
Hallmark Associated Signs	Skin blistering, nail dystrophy/absence, mucosal lesions	Terminal transverse limb defects, CMTC, congenital heart defects	Distichiasis (double-row/sparse/absent lashes), upward eyebrows, leonine facies
Key Genes	COL7A1 (Type VII collagen in DDEB; also simplex/junctional EB)	ARHGAP31, DOCK6, EOGT, RBPJ, NOTCH1, DLL4	TWIST2
Inheritance	Depends on EB subtype (originally DDEB)	Autosomal Dominant or Recessive (gene-dependent)	Generally Autosomal Recessive
Crucial Exam Pitfall	NOT synonymous with DDEB in every case (occurs in simplex/junctional too)	Marked intrafamilial variability; needs cardiac & limb workup	Do NOT confuse bitemporal scars with actual obstetric forceps trauma

💡 Memory Key — Adams–Oliver 6 Genes ("DARE-ND"): DOCK6, ARHGAP31, RBPJ, EOGT + Notch pathway pair (NOTCH1, DLL4).

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

متلازمة بارت (Bart): في الساقين (ثنائية ومتناظرة) + فقاعات انحلال البشرة (EB) وتشوه الأظافر. انتبه: وُصفت أصلًا مع النوع الحثلي السائد (DDEB / جين COL7A1) لكنها قد تحدث مع أنواع EB الأخرى، لذا يفضل حاليًا تسميتها (EB with congenital absence of skin).
متلازمة آدامز-أوليفر (Adams–Oliver): في قمة الرأس + بتر أو نقص أطراف الأصابع النهائي + جلد مرقط وعائي (CMTC) + عيوب قلبية.
متلازمة سيتليس (Setleis / FFDD3): ندبات في الصدغين تشبه علامات ملقط الولادة + رموش مزدوجة الصفوف (Distichiasis) أو غائبة + حواجب مائلة للأعلى وملامح أسدية (Leonine facies) بسبب جين TWIST2.

2. Differential Diagnosis (7 Look-Alikes to Distinguish from ACC)

Differential Matrix

Condition	How It Mimics ACC	Key Distinguishing Clue
1. Birth Trauma	Scalp/facial erosion at delivery	History of forceps, vacuum extraction, or fetal scalp monitor
2. Epidermolysis Bullosa (EB)	Congenital erosions/blisters at birth	Subsequent new blisters after minimal trauma (Note: overlaps as Type VI ACC)
3. Encephalocele / Meningocele	Membrane-covered scalp lesion	Imaging is essential to detect communication with intracranial structures
4. Congenital Dermoid Cyst	Scalp or craniofacial congenital lesion	Cystic mass anatomy rather than primary absence of skin layers
5. Intrauterine Infections	Cutaneous scarring or erosions at birth	Maternal/fetal varicella or HSV history (also classified under Frieden Type VIII)
6. Focal Dermal Hypoplasia (Goltz)	Congenital linear or patchy skin defects	Accompanied by other characteristic syndromic features of Goltz syndrome
7. Sebaceous Nevus	Congenital scalp plaque with alopecia	Characteristic surface appearance and distinct sebaceous histology

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

أخطر تشبيه: القيلة الدماغية أو السحائية (Encephalocele / Meningocele) قد تبدو كآفة غشائية في فروة الرأس، والتصوير الإشعاعي ضروري جدًا لكشف اتصالها بداخل الجمجمة.

Frieden Classification (1986) — Types I to IX Master Reference & Self-Test

Hardest-to-Remember Drill

Frieden Type	Clinical Characteristics (Click hidden row to reveal)	Modern Update / Note
Type 1	Scalp ACC without associated multiple anomalies	Most common isolated presentation
Type 2	Scalp ACC + limb abnormalities (includes Adams–Oliver syndrome)	Check heart, CMTC, skull defect
Type 3	Scalp ACC + epidermal and organoid nevi	Nevus association
Type 4	ACC overlying embryologic malformations	High risk for deep underlying defects
Type 5	ACC associated with fetus papyraceus or placental infarction	Vascular / ischemic mechanism
Type 6	ACC associated with epidermolysis bullosa (Bart syndrome)	Term "EB with congenital absence of skin" preferred
Type 7	ACC of the extremities without epidermolysis bullosa	No blistering / no EB
Type 8	ACC associated with teratogenic exposure or intrauterine infection	Later studies split into 2 subgroups: teratogenic & infective
Type 9	ACC associated with congenital malformation syndromes	Syndromic ACC

⚡ Quick Fire: High-Risk Numbers & Eponyms Check

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

تصنيف فريدن (1986): يقسم ACC إلى 9 أنواع من (Type 1 المعزول في الرأس) حتى (Type 9 المرتبط بمتلازمات التشوهات). اقترحت دراسات لاحقة تقسيم (Type 8) إلى مجموعتين فرعيتين: ماسخة (Teratogenic) وإنتانية (Infective).

Clinical Categorization Sorter — Click an Item, Then Click Its Correct Group

Sorted: 0 / 12

Select any chip below to start sorting...

1. Adams–Oliver (Type II)

2. Bart Syndrome (Type VI)

3. Setleis Syndrome (FFDD3)

4. Type VIII (Teratogens/Infections)

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

انقر على أي عنصر في الأعلى ثم انقر على الصندوق الصحيح بالأسفل لتصنيف الجينات والعلامات السريرية والعوامل المسببة. سيظهر لك تنبيه فوري عند الخطأ.

Active-Recall Flashcards (Spaced Queue)

Card 1 / 12 | Mastered: 0

QUESTION (Click or Press Space to Flip)

إضافة مساعدة للشرح (ليست جزءًا من نص المصدر)

اضغط على البطاقة (أو مسطرة المسافة Space) لقلبها. البطاقات التي تختار لها Still Learning ستعود إليك تلقائيًا حتى تتقن المجموعة كاملة.

Clinical Board-Style MCQ Exam

Score: 0 / 10

Exam-Eve Ultra-Rapid Keyword Sheet (60-Second Scan)

Bare Keywords

1. Core Numbers & Sites

• Clinical Incidence: 1–3 / 10,000 live births

• Euro Study: 5.1 / 100,000 births

• #1 Site: Scalp vertex (midline)

• Imaging Size Cutoff: > 4 cm

• Frieden Year / Groups: 1986 / 9 types

2. Red Flags & Contraindications

• Hair Collar Sign: Ring of dark/long hair → neural tube / cranial defect

• Membranous Scalp ACC: Underlying skull defect

• Biopsy Rule: Image BEFORE biopsy/excision

• Topical Caution: Avoid silver sulfadiazine (systemic absorption)

3. Teratogens & Infections (Type VIII)

• Antithyroid: Methimazole, Carbimazole

• Other Drugs: Valproate, Misoprostol

• Viruses: Varicella, HSV

• Type V Vascular: Fetus papyraceus, placental infarct

4. Syndrome Triad Summary

• Bart (Type VI): Lower legs + EB + Nail loss (COL7A1; not only DDEB)

• Adams–Oliver (Type II): Vertex + Terminal limb defects + CMTC + Heart (6 genes)

• Setleis (FFDD3): Bitemporal forceps scars + Distichiasis + Leonine facies (TWIST2, AR)

Medical Disclaimer: This interactive study tool is strictly derived from the provided source text for educational purposes only and does not replace professional medical assessment, diagnosis, or treatment.

Source References (With Publication / Update Dates):

Brackenrich J, Saleh HM, Brown A. Aplasia Cutis Congenita. StatPearls. Updated August 19, 2025. (ncbi.nlm.nih.gov/books/NBK535403/)
Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986;14(4):646–660.
Humphrey SR, Hu X, Adamson K, et al. A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita. J Perinatol. 2018;38:110–117.
Sathishkumar D, Ogboli M, Moss C. Classification of aplasia cutis congenita: a 25-year review of cases presenting to a tertiary paediatric dermatology department. Clin Exp Dermatol. 2020;45(8):994–1002.
Coi A, Barisic I, Garne E, et al. Epidemiology of aplasia cutis congenita: a population-based study in Europe. J Eur Acad Dermatol Venereol. 2023;37(3):581–589.
DermNet. Aplasia cutis congenita & Epidermolysis bullosa with congenital absence of skin. (dermnetnz.org)
Hassed S, Li S, Mulvihill J, Aston C, Palmer S. Adams–Oliver syndrome review of the literature: refining the diagnostic phenotype. Am J Med Genet A. 2017;173(3):790–800.
Online Mendelian Inheritance in Man (OMIM). Focal facial dermal dysplasia 3, Setleis type (FFDD3). OMIM #227260.

Miliaria (Heat Rash): Interactive Clinical Study & Mastery Tool

2026-10-31T00:15:03.253+00:00

Interactive study tool · Dermatology · Sweating disorders

Miliaria Crystallina & Miliaria Rubra

Heat rash · Sweat rash · Prickly heat

GoJump to the question you have

Q1What is miliaria?

Also calledheat rash · sweat rash · prickly heat

Causeobstruction or disruption of eccrine sweat ducts

Resultsweat retention within the skin

Lesion typevesicles or papules — depends on the level of ductal involvement

Two formsMC = most superficial · MR = deeper, inflammatory

Settinghot and humid environments

Agesall ages · infants especially susceptible

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

الفكرة كلها: قناة العرق تنسدّ أو تتمزّق، فيُحبس العرق داخل الجلد.

عمق الانسداد هو ما يحدد شكل الحبوب.

النوع البلوري (MC) هو الأسطحي، والأحمر (MR) أعمق ومعه التهاب.

يكثر في الجو الحار الرطب، والرُّضّع أكثر عرضة له.

Q2Where is the block? — the difference that explains everything

Tap a level to isolate it.

MCblock in stratum corneum or immediately beneath → sweat in superficial intraepidermal space → clear vesicles · little or no inflammation

MRblock at mid-epidermis → sweat retention + leakage into surrounding epidermis → inflammatory response → erythematous papules and papulovesicles

Profundasweat retention in the dermis · may occasionally follow repeated MR

Miliaria rubra→ repeated episodes →Miliaria profunda (occasionally)

Memory aid (study addition)

Crystallina = crystal clear · top layer · calm (no inflammation)

Rubra = ruby red · mid-epidermis · itchy

From MC to MR: deeper → redder → itchier → bigger (1–2 mm → 2–4 mm)

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

في MC يكون الانسداد في الطبقة القرنية، وهي أعلى طبقة، فتظهر فقاعات شفافة بلا التهاب.

في MR يكون الانسداد في منتصف البشرة، فيتسرب العرق إلى ما حوله ويسبب التهابًا واحمرارًا وحكة.

في Profunda يُحبس العرق في الأدمة، وهي الأعمق، وقد تأتي بعد نوبات متكررة من MR.

Q3How does each one look and feel?

Miliaria crystallina

Lesiontiny, clear, superficial vesicles

Size1–2 mm

Looklike droplets of water or beads of sweat

Rednessno significant erythema

Symptomsusually no itching, burning, or pain

Fragilityrupture easily → fine bran-like scaling

Sitesforehead · scalp · neck · upper trunk

Newbornshead · neck · upper body

Miliaria rubra

Lesionerythematous, non-follicular papules and papulovesicles

Size2–4 mm

Backgroundsurrounding erythema

Symptomsitching · prickling · stinging · burning

Worse withsweating · heat exposure

Sitesneck · upper chest/back · forehead and scalp margins · axillae · groin and folds · under tight clothing

Infantstrunk + folds of neck, axillae, groin

Adultsupper trunk · neck · clothing-friction areas

Miliaria pustulosa

Whatpustular variant of MR — pustules instead of papules

Trappustules may suggest infection → do not assume it without supporting findings

Miliaria profunda

Whatdeeper, skin-colored papules

Sweatingmore significant impairment

Tell MC from MR in 3 questions (study addition)

1 · Clear or red? → clear = MC · red = MR

2 · Silent or itchy? → silent = MC · itchy/prickly = MR

3 · 1–2 or 2–4 mm? → small = MC · larger = MR

Pustulosa = pustules · Profunda = profound (deep)

Feature	Miliaria crystallina	Miliaria rubra
Level of obstruction	Stratum corneum or immediately beneath it	Mid-epidermis
Primary lesions	Clear superficial vesicles	Erythematous papules and papulovesicles
Inflammation	Absent or minimal	Prominent
Itching	Usually absent	Common
Appearance	Tiny water-like droplets	Small inflamed bumps
Common age groups	Particularly newborns	Infants, children, and adults
Clinical course	Usually rapidly self-limiting	May persist longer if heat and sweating continue

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

MC: قطرات ماء شفافة صغيرة (1–2 مم)، بلا احمرار ولا حكة، تنفجر بسهولة وتترك قشورًا ناعمة تشبه النخالة.

MR: حبوب حمراء (2–4 مم) لا تتمركز حول بصيلات الشعر، معها حكة ووخز، وتزيد مع التعرق.

Pustulosa: صورة بثرية من MR، ووجود البثور لا يعني تلقائيًا أن هناك عدوى بكتيرية.

Q4Who gets it, and when?

Worldwidemore with excessive sweating, high temperature, humidity

Infantseccrine ducts relatively immature

MC · babiesneonates, first weeks of life · up to ~9% of newborns

MC · adultsfebrile illness or excessive heat

MRmost common form · infants, children, adults · prolonged sweating in hot, humid conditions

MR · classicpeople moving to tropical climates or suddenly exposed to heat

Bedriddenprolonged occlusion + limited ventilation

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

MC شائع عند حديثي الولادة في الأسابيع الأولى (حتى نحو 9%)، ويصيب الكبار مع الحمى أو الحر الشديد.

MR هو الأكثر شيوعًا، ويصيب كل الأعمار، وبخاصة من ينتقل إلى مناخ استوائي.

المرضى طريحو الفراش معرَّضون له بسبب تغطية الجلد طويلًا وقلة التهوية.

Q5Why does it happen?

Memory aid (study addition): a SOLID plug blocks the duct

S · Sweatingexcessive sweating: hot weather · high humidity · physical activity · fever

O · Occlusiontight clothing · excessive wrapping · bedding contact · occlusive dressings

L · Local skinprolonged moisture · friction · occlusion

I · Immature ductsexplains why newborns are susceptible

D · Duct blockabnormal keratinization + plugging of duct openings · duct-wall disruption lets sweat escape

1 · Duct blockedobstruction or disruption

2 · Sweat retainedcannot reach the surface

3 · Lesions formvesicles or papules, depending on the level

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

كلمة SOLID تجمع الأسباب: تعرّق زائد، وتغطية الجلد، وظروف موضعية (رطوبة واحتكاك)، وقنوات غير مكتملة النمو، وانسداد القناة.

التسلسل: تنسد القناة ← يُحبس العرق ← تظهر الحبوب.

Q6How is it diagnosed?

Main methodclinical: appearance + distribution + history of heat, sweating, or occlusion

MC findingclear, superficial, fragile vesicles without inflammation

MR findingerythematous non-follicular papules and papulovesicles + itch or prickling

Labsnot required in typical cases

Dermoscopyoptional, in selected patients

Biopsyrarely needed · only for persistent, recurrent, or atypical cases

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

التشخيص سريري بالشكل والقصة المرضية، ولا تلزم تحاليل في الحالات المعتادة. الخزعة نادرة، للحالات المستمرة أو المتكررة أو غير المعتادة.

Q7What can look like it? — clue → think

Neonatal acnepapules and pustules on the cheeks, forehead, nose · follicular

Erythema toxicummacules, papules, pustules with a red halo · starts in the first days of life

TNPMpustules → pigmented macules ± collarette of scale · often present at birth

Folliculitiscentered on hair follicles

Contact dermatitisfollows irritant or allergen exposure · the distribution matches the exposure

Neonatal infectionHSV or bacterial · exclude if fever, poor feeding, lethargy, or rapid spread

Key separator (study addition)

Miliaria = non-follicular · acne and folliculitis = follicular

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

أهم فاصل أن حبوب الميليريا لا تتمركز حول بصيلات الشعر، بخلاف حب الشباب والتهاب الجريبات.

إن ظهر على الرضيع حمى أو ضعف رضاعة أو خمول، فيجب استبعاد العدوى، مثل الهربس.

Q8How is it treated?

Goalsreduce sweating · restore evaporation · calm inflammation

Both formscool, ventilated room · light, loose, breathable fabrics · no over-wrapping · remove wet clothes · treat fever

Avoidheavy, occlusive creams and ointments · excessive washing or rubbing

MCno specific medication · cool the skin · do not squeeze or pop the vesicles

MR · mildcooling + less sweating + no occlusion

MR · itchyshort course of a topical corticosteroid, chosen by a clinician · low-potency for children and sensitive areas

MR · soothingcalamine · cool compresses · cool baths

Infantssteroids cautiously, only on professional advice

Antibioticsnot routine · only if a bacterial infection is clinically diagnosed

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

العلاج الأساسي هو التبريد وتقليل التعرق ولبس ملابس خفيفة، مع تجنب الكريمات الثقيلة.

MC لا يحتاج إلى دواء. وفي MR قد يصف الطبيب كورتيزونًا موضعيًا خفيفًا لمدة قصيرة، ولا تُعطى المضادات الحيوية روتينيًا.

Q9Complications and prognosis

Usual courseuncomplicated · no permanent damage

Infectionsecondary bacterial infection, especially after scratching

Recurrencehappens if the heat and sweating continue

Sweatingtemporary impairment → if extensive, risk of heat-related illness

Progressionrepeated MR → occasionally profunda

Prognosisexcellent · MC resolves rapidly · MR may persist longer with continued exposure

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

المآل ممتاز في الغالب. المضاعفات الممكنة: عدوى بعد الحكّ، أو تكرار الطفح، أو ضعف التعرق الذي قد يرفع خطر أمراض الحرارة.

Q10When to seek medical assessment

Rashwidespread, persistent, or worsening

Lesionspainful · markedly inflamed · extensive pustules

Infantfever · poor feeding · lethargy

Uncertaina newborn with vesicles or pustules

Overheatingweakness · altered consciousness · high temperature

شرح مساعد بالعربية · إضافة للتبسيط وليس من المصدر

راجع الطبيب إذا انتشر الطفح أو استمر، أو ظهرت على الرضيع علامات مرض عام، أو ظهرت علامات ارتفاع شديد في حرارة الجسم.

Sources · tool compiled October 2026

1. Palaniappan V, Sadhasivamohan A, Sankarapandian J, Karthikeyan K. Miliaria crystallina. Clin Exp Dermatol. 2023;48(5):462–467. doi.org/10.1093/ced/llad032

2. Merck Manual Professional Edition. Miliaria. Reviewed June 2026. merckmanuals.com

3. DermNet New Zealand. Miliaria (Heat Rash). dermnetnz.org

4. Guerra KC, Toncar A, Krishnamurthy K. Miliaria. StatPearls, NCBI Bookshelf. ncbi.nlm.nih.gov

5. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38(1):1–17. pubmed

Educational use only. This does not replace professional medical assessment. Memory aids and Arabic notes are study additions, not part of the source.

Seborrheic Dermatitis: High-Yield Interactive Clinical Study Tool

2026-10-29T23:42:09.011+00:00

Interactive study tool · Dermatology

Seborrheic Dermatitis

Guide · Learn · Cards · Quiz · Who's who · Sort · Night review

Q1What exactly is seborrheic dermatitis?

TypeCommon, chronic, relapsing inflammatory skin condition
WhereAreas rich in sebaceous glands
PatchesPoorly defined redness or discoloration
ScaleFine white scales or yellowish, greasy scaling
DandruffMild scalp SD: flaking predominates, inflammation minimal or absent
InfantsRelated scalp presentation = cradle cap

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرهو التهاب جلدي شائع ومزمن، يهدأ ثم يعود، ويظهر في الأماكن الغنية بالغدد الدهنية. شكله بقع غير واضحة الحدود، حمراء أو متغيرة اللون، عليها قشور بيضاء ناعمة أو صفراء دهنية. القشرة (Dandruff) أخف صوره في فروة الرأس، وعند الرضّع تسمّى «قبعة المهد».

Q2Who gets it, and how does it behave over time?

WhoWorldwide, all skin types
AgesCommon in infancy and adulthood
InfantStarts in the first months of life, usually improves spontaneously
AdultOften persists for years: remission ↔ exacerbation
Severe inNeurological disorders incl. Parkinson disease, plus HIV / impaired immune function
CautionSD alone does not establish an underlying systemic disorder

Infant course: self-limiting · Adult course: relapsing waves

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدريصيب الناس في كل العالم وبكل ألوان البشرة. عند الرضيع يبدأ في الشهور الأولى ويتحسن وحده غالبًا. عند البالغ يستمر سنوات، يهدأ مرة وينشط مرة. قد يكون أشد مع باركنسون أو ضعف المناعة مثل HIV، لكن وجوده وحده لا يثبت وجود مرض عام.

Q3Why does it happen?

StatusPathogenesis incompletely understood
ModelInteraction of microbes + sebum + barrier + host inflammation
MalasseziaLipid-dependent yeasts, normal skin inhabitants
MechanismYeast activity + lipid-metabolism products → inflammation + scaling in susceptible people
NotNot simply a fungal infection: needs extra host and environmental factors
SebumSebum-rich distribution supports a lipid role, but not solely excess sebum
BarrierAltered epidermal barrier + individual immune response → scaling, irritation
TriggersCold or dry weather · psychological stress · neuro/immune conditions
VariationWeight of each factor varies between individuals
MythsNot poor hygiene · not contagious

Disease = overlap, not one cause

Memory key

“My Skin's Barrier Inflames”

Malassezia · Sebum · Barrier · Inflammatory response, the 4 interacting factors

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرليس له سبب واحد، بل هو نتيجة تفاعل أربعة أشياء: خميرة الملاسيزيا الموجودة طبيعيًا على الجلد، ودهون الجلد، وحاجز الجلد، ورد فعل المناعة. لذلك هو ليس عدوى فطرية بسيطة، ولا ينتج عن قلة النظافة، ولا ينتقل بالعدوى. يزيد مع البرد والجفاف والضغط النفسي.

Q4Where does it appear, and what does each site look like?

Red dots = frequent sites (sebaceous-rich areas + skin folds)

Scalp

Dandruff
flaking · minimal/no inflammationInflammatory scalp SD
erythema/discoloration · greasy scales

RangeFrom mild dandruff to more inflammatory disease
ScaleFine white flakes or yellowish, greasy scales
BeneathVariable erythema or discoloration
ItchAbsent or varies in intensity
ExtentScaling may extend beyond the hairline
Hair lossNot a defining feature. Significant/patchy loss → think another or additional diagnosis

Face

MainEyebrows · glabella · nasolabial folds · sides of nose · beard/moustache
AlsoForehead · eyelid margins
LesionPoorly demarcated patches, fine or greasy scales
Dark skinLess visibly red. Lighter or darker patches stand out more

Ears

SitesExternal ear · behind the ears · entrance of external auditory canal
LookScaling + fissuring, esp. folds behind ears
WarningDeeper canal pain or discharge → assess other conditions

Chest and skin folds

TrunkScaly patches on upper chest and back
FoldsArmpits, groin: inflammation > scaling
Varies bySite · severity · age · skin tone

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرأشهر أماكنه: فروة الرأس، والحاجبان، وما بين الحاجبين، وجانبا الأنف، والأذنان، وأعلى الصدر، وثنيات الجلد. في الثنيات يغلب الالتهاب على القشور. في البشرة الداكنة قد لا يظهر الاحمرار بوضوح، وتظهر بدلًا منه بقع أفتح أو أغمق. تساقط الشعر الواضح، وألم الأذن من الداخل مع إفرازات، ليسا من علاماته المعتادة.

Q5What about infants (cradle cap)?

LookAdherent white or yellowish scalp scales
AlsoFace · eyebrows · skin folds
FeelGenerally not itchy or painful, infant not disturbed
CourseImproves over weeks to months, commonly resolves in the first year
Not typicalWidespread inflammation · marked discomfort · swelling · oozing · bleeding · pustules → assess

Home care (mild cradle cap)

WashMild baby shampoo
LoosenGentle massage or a soft brush
SoftenEmollient for stubborn scales → then gentle wash
NeverForcibly scrape or pick scales
AvoidAdult dandruff shampoos / medicated products without professional advice
Assess ifPersistent · widespread · inflamed · oozing

Stop-sign list · infant

Widespread · Discomfort · Swelling · Oozing · Bleeding · Pustules: none of these fit uncomplicated cradle cap.

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدر«قبعة المهد» قشور ملتصقة بيضاء أو صفراء على رأس الرضيع، لا تحكه ولا تؤلمه، وتزول غالبًا خلال السنة الأولى. العناية بها: شامبو أطفال لطيف، وفرشاة ناعمة، ومطرّي للقشور العنيدة. لا تُنزع القشور بالقوة، ولا يُستعمل شامبو الكبار إلا باستشارة. أما التورم أو النزّ أو النزف أو البثور أو الانزعاج الواضح فيستدعي الفحص.

Q6How is it diagnosed?

BasisClinical: appearance + distribution + recurrent course
LabsRoutine tests generally unnecessary in typical cases
Fungal testWhen the diagnosis is uncertain
BiopsyRarely needed: unusual or persistent lesions
Look harderUnusually severe · widespread · atypical · treatment-resistant

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدريُشخَّص غالبًا بالفحص: شكل البقع، ومكانها، وتكرار الحالة. التحاليل الروتينية لا تلزم عادة. يُفحص للفطريات عند الشك، والخزعة نادرة. يلزم تقييم أعمق إذا كانت الحالة شديدة أو منتشرة أو غير معتادة أو لا تستجيب للعلاج.

Q7What else could it be? Untangling the look-alikes

Condition	Key clue	Distinguishing detail	Relation to SD
Seborrheic derm.	Poorly defined patches, fine/greasy scale	Sebaceous-rich sites, recurrent	(reference)
Psoriasis	Sharply demarcated plaques, thicker scales	Plaques elsewhere · nail changes	Can coexist = sebopsoriasis
Atopic derm.	Dry, itchy, inflamed skin	Personal/family history of atopy	Overlap esp. in infants
Contact derm.	Scalp, face, eyelids, ears after a product	Exposure history + distribution	Allergic or irritant
Tinea capitis	Fungal infection of scalp	Broken hairs · patchy hair loss · ± inflammatory lesions	Think in children with scaling + hair loss
Rosacea	Central facial redness, flushing	Inflammatory papules/pustules; greasy scale less typical	May coexist
Others	Other eczemas · infections	Candidiasis in skin folds	Site-dependent

Trap · not a discriminator

Scaling beyond the hairline can occur in both SD and psoriasis, so use border sharpness, scale thickness, plaques elsewhere and nails instead.

Memory key

Rule SD out with a PACT-R

Psoriasis · Atopic · Contact · Tinea capitis · Rosacea (+ candidiasis in folds)

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرأهم ما يشبهه: الصدفية (حدود حادة، وقشور أسمك، وتغيرات في الأظافر)، والأكزيما التأتبية (جفاف وحكة وتاريخ حساسية)، والتهاب الجلد التماسي (يظهر بعد منتج أو عطر)، وسعفة الرأس (تكسّر الشعر وتساقطه عند الأطفال)، والوردية (احمرار وسط الوجه وبثور). انتبه: امتداد القشور خارج خط الشعر يحدث في الصدفية والتهاب الجلد الدهني معًا، فلا يفرّق بينهما.

Q8How is it treated?

4 aimsControl inflammation · reduce scaling · decrease Malassezia · prevent recurrence
Choice bySite · severity · age · previous response

Scalp

First-lineMedicated shampoos
OptionsKetoconazole · ciclopirox · selenium sulfide · zinc pyrithione (where available)
Thick scaleKeratolytic, e.g. salicylic acid
FrequencyPer product instructions: regular when active → intermittent maintenance after
SteroidSubstantial inflammation/itch → clinician-prescribed scalp solution, foam or lotion, limited period
AvoidProlonged or inappropriate corticosteroid use

Memory key · scalp shampoo ingredients

“Keep Calm, Scalp Zone Saved”

Ketoconazole · Ciclopirox · Selenium sulfide · Zinc pyrithione · Salicylic acid (thick scales)

Face and body

BaseTopical antifungals: ketoconazole or ciclopirox
InflamedShort course of low-potency topical corticosteroid
CautionFace · eyelids · skin folds: more prone to steroid adverse effects
TCIsTacrolimus / pimecrolimus: selected cases, when repeated steroids undesirable
LabelTCIs for SD = off-label in many jurisdictions
Skin careGentle cleansing · fragrance-free products · moisturizer (barrier)

Escalation and maintenance

1Topical antifungal: shampoo (scalp) or topical agent (face/body)
2+ Short anti-inflammatory: suitable topical corticosteroid. TCI in selected cases
3Extensive / non-responsive → dermatological review: recheck diagnosis, adherence, contributing conditions
4Specialist, selected severe cases: systemic antifungals · phototherapy · other targeted therapies. Not routine first-line, individualized (efficacy, contraindications, interactions, adverse effects)
↻Maintenance: intermittent antifungal shampoo/topical. Goal = sustained control, not a guaranteed cure

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرالهدف السيطرة على المرض، لا الشفاء النهائي المضمون. للرأس تُستعمل الشامبوهات الطبية أولًا. للوجه والجسم يُستعمل مضاد فطري موضعي، ومعه كورتيزون خفيف لفترة قصيرة إذا اشتد الالتهاب، مع الحذر في الوجه والجفون والثنيات. مثبطات الكالسينيورين لحالات مختارة. الحالات الصعبة يراجعها طبيب جلدية، وبعد التحسن يستمر علاج وقائي متقطع.

Q9What is the outlook?

OverallGenerally manageable, depends on age + susceptibility
AdultsRecurrence common, long-term intermittent treatment
InfantsFavorable, often resolves spontaneously
ComplicationsIrritation · fissuring · secondary infection after skin damage · post-inflammatory pigment change
Not typicalSignificant hair loss · persistent scarring → look for another diagnosis

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدريمكن التحكم فيه عمومًا. عند الكبار يعود كثيرًا، وعند الرضّع يزول غالبًا من تلقاء نفسه. مضاعفاته المحتملة: تهيّج، وتشققات، وعدوى ثانوية بعد تضرر الجلد، وتغيّر لون الجلد بعد الالتهاب. أما الندبات الدائمة وتساقط الشعر الشديد فليسا من طبيعته.

Q10When should someone be assessed?

UnsureDiagnosis uncertain / resembles another condition
SeveritySevere · widespread · painful · persists despite treatment
InfectionMarked swelling · oozing · bleeding · pus
ChildSignificant hair loss or widespread rash
InfantExtensive inflammation · discomfort · no improvement with gentle care

شرح مساعد بالعربية · إضافة للتبسيط، ليس من المصدرتلزم مراجعة الطبيب في هذه الحالات: إذا لم يكن التشخيص مؤكدًا، أو كانت الأعراض شديدة أو منتشرة أو مؤلمة أو لا تتحسن بالعلاج، أو ظهرت علامات عدوى كالتورم والنزّ والصديد، أو ظهر عند الطفل تساقط شعر واضح أو طفح منتشر، أو لم يتحسن الرضيع بالعناية اللطيفة.

Choose the right word in each bracket, then press Check0 / 0

Wrong picks turn red; “Show” outlines the right answer. C checks all.

شرح مساعد بالعربية · إضافة، ليس من المصدراختر الكلمة الصحيحة من كل قوسين، ثم اضغط «Check». الخطأ يظهر بالأحمر، و«Show» يبيّن الإجابة الصحيحة. كل جملة تكملها صحيحة تُحسب في تقدّمك.

Known 0 / 0

Question · tap to flip

Answer

شرح مساعد بالعربية · إضافة، ليس من المصدراقلب البطاقة. إذا اخترت «Got it» تخرج البطاقة من الدورة. إذا اخترت «Not yet» تعود إليك بعد ثلاث بطاقات حتى تثبت. «Only not-yet» يعرض ما لم تحفظه بعد فقط.

شرح مساعد بالعربية · إضافة، ليس من المصدراختر الإجابة بالضغط أو بالحروف A–D، ويظهر بعدها سبب الإجابة. في النهاية يمكنك إعادة الأسئلة التي أخطأت فيها فقط.

شرح مساعد بالعربية · إضافة، ليس من المصدرهذا تمرين لأصعب ما يُنسى في الموضوع: التفريق بين الأمراض المتشابهة. تظهر لك علامة، فاختر المرض الذي تدل عليه (A–H). انتبه للفخ: بعض العلامات مشتركة بين مرضين. يُحسب أطول تسلسل صحيح لك.

Tap an item, then tap its group (or drag it). Keys: A–D drop the selected item.

شرح مساعد بالعربية · إضافة، ليس من المصدراضغط على العنصر ثم على مجموعته الصحيحة، أو اسحبه إليها. إذا أخطأت تنبهك الأداة فورًا، وبعد خطأين في العنصر نفسه تظهر لك المجموعة الصحيحة.

Exam-eve keywords

Definition

chronicrelapsinginflammatorysebaceous-rich areaspoorly defined patchesfine white scaleyellow greasy scale

Dandruff / cradle cap

dandruff = mild scalp SDflaking ↑ inflammation ↓cradle cap = infant scalp

Course

infant: first monthsself-improvesresolves ~1st yearadult: yearsremission ↔ flare

Severe / extensive in

Parkinson diseaseHIVimpaired immunity≠ proof of systemic disease

Cause · MSBI

Malassezia (normal, lipid-dependent)Sebum (not solely)BarrierInflammatory response

Triggers / myths

cold-dry weatherstressneuro/immunenot hygienenot contagiousnot simple fungal infection

Sites

scalpeyebrowsglabellanasolabialsides of noseearsbeardupper chest/backfolds

Site pearls

folds: inflammation > scaledark skin: less redlighter/darker patchesears: fissuring behind

Not SD → reassess

significant/patchy hair losspersistent scarringdeep ear pain/dischargeinfant: ooze · bleed · pustules · swelling

Cradle cap care

baby shampoosoft brushemollient → washnever pick/scrapeno adult shampoo w/o advice

Diagnosis

clinicalno routine labsfungal test if unsurebiopsy rarely

Look-alikes · PACT-R

Psoriasis: sharp · thick · nailsAtopic: atopy · infantsContact: exposureTinea: child + hair lossRosacea: flush · pustulescandidiasis: foldssebopsoriasis

Scalp Rx · KCSZS

ketoconazoleciclopiroxselenium sulfidezinc pyrithionesalicylic acid (thick)scalp TCS: short

Face / body Rx

ketoconazole / ciclopiroxlow-potency TCS shorttacrolimus · pimecrolimusoff-labelfragrance-free + moisturizer

Severe / resistant

derm reviewrecheck dx · adherencesystemic antifungalsphototherapytargeted therapynot first-line

Goal / prognosis

control ≠ cureintermittent maintenanceirritationfissuringsecondary infectionpigment change

شرح مساعد بالعربية · إضافة، ليس من المصدرهذه صفحة ليلة الامتحان: الكلمات المفتاحية وحدها. فعّل «hide keywords» لتختبر نفسك، ثم اضغط على أي كلمة لتكشفها.

Pedal Papules of Infancy: Interactive Clinical Study Tool

2026-10-29T19:06:25.382+00:00

Pedal Papules of Infancy

Study tool built only from the supplied source. Click here, then Alt+1 to Alt+6 switches modes.

Subcutaneous Fat Necrosis of the Newborn (SCFN): Interactive Clinical Study Tool

2026-10-28T13:57:12.014+00:00

SCFN · Subcutaneous Fat Necrosis of the Newborn

Interactive study tool · Learn → Test → Fix the traps → Night review

Learn — organized by the questions you actually ask

Read the highlighted words first. Mark each section when understood.

Sources

1. DermNet. Subcutaneous fat necrosis of the newborn. DermNet NZ, online clinical reference (accessed October 2026).

2. Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: a systematic review of the literature. Pediatric Dermatology, 2019.

3. Siegel LH, et al. Subcutaneous fat necrosis of the newborn: a retrospective study of 32 infants and care algorithm. Pediatric Dermatology, 2023;40(3):413–421.

4. Velasquez JH, Mendez MD. Subcutaneous Fat Necrosis of the Newborn. StatPearls Publishing (continuously updated online; 2023–2025).

5. Frank L, et al. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology. 2022.

Disclaimer: Educational use only; does not replace professional medical assessment. Newborns with suspected SCFN require evaluation by a qualified healthcare professional, including monitoring for metabolic complications.

Sclerema Neonatorum: High-Yield Interactive Clinical Study Tool

2026-10-25T21:08:21.459+00:00

Sclerema Neonatorum Mastery Tool

Neonatal Induration Triad: Critical Diagnostic Divergence

Q1: What Is Sclerema Neonatorum & Why Is It Life-Threatening?

Definition, clinical nature, and target population

Condition NatureRare, potentially life-threatening disorder of neonatal skin and subcutaneous adipose tissue.

Hallmark SignDiffuse hardening of the skin and subcutaneous fat.

Target PopulationPredominantly critically ill, premature, or low-birth-weight (LBW) infants.

Peak OnsetTypically manifests during the first week of life (often first few days).

Core Clinical IdentityA marker of critical underlying systemic disease, NOT an isolated skin disorder.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

تصلب حديثي الولادة (Sclerema Neonatorum) هو اضطراب نادر وشديد الخطورة يهدد الحياة، يتميز بتصلب جلدي ودهني منتشر في الأسبوع الأول من عمر الأطفال الخدج أو ناقصي الوزن المصابين بأمراض جهازية حرجة. هو ليس مرضًا جلديًا معزولاً بل علامة على مرض جهازي حرج يهدد حياة الرضيع.

Q2: What Causes Sclerema Neonatorum & What Is the "Cold Misconception"?

Etiology, systemic associations, and thermal misconceptions

PathogenesisIncompletely understood; mechanisms of diffuse induration are not definitively established.

Systemic TriggersSevere sepsis, respiratory distress, circulatory compromise, hypothermia, metabolic disturbances.

Fat CompositionProposed abnormalities in neonatal subcutaneous fat composition and tissue structure contribute to firmness.

⚠️ Critical Misconception: Cold Exposure

Cold Exposure MythSclerema neonatorum should NOT be regarded simply as a consequence of cold exposure; its presence demands urgent evaluation for severe underlying systemic illness.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

الآلية الدقيقة غير مفهومة بالكامل حتى الآن، وترتبط بخلل في تركيبة الدهون تحت الجلد واضطرابات الأيض. خطأ شائع: لا يجوز اعتبار هذا التصلب مجرد نتيجة لتعرض الرضيع للبرد، بل هو دائمًا مؤشر يستوجب البحث الفوري عن تعفن الدم (Sepsis) أو صدمة دورانية أو فشل تنفسي.

Q3: What Are the Characteristic Physical Examination Findings?

Skin texture, anatomical distribution, and spared areas

Tissue TextureDiffuse, firm, board-like induration of the skin and subcutaneous tissue.

Pitting StatusNon-pitting consistency (distinguishes it from ordinary fluid-related edema).

Mobility / PinchingSkin is tightly bound to underlying tissues and cannot readily be pinched or moved.

Anatomical SpreadExtensive/spreading: thighs, buttocks, trunk, and extremities.

Spared SitesThe palms and soles are often relatively spared (distribution can vary).

Skin ColorSkin may appear pale, yellowish, mottled, or purplish.

Functional ThreatRestricts movement; in severe cases, directly interferes with respiration and feeding.

Systemic StateTemperature instability, lethargy, poor feeding, respiratory failure, cyanosis, shock, and multiorgan failure.

MNEMONIC: THE "B-O-A-R-D" SIGN

• Board-like non-pitting induration (cannot be pinched).
• Often spares palms and soles.
• Associated with sepsis and multiorgan compromise.
• Restricts thoracic movement (interferes with breathing & feeding).
• Diffuse spreading over thighs, buttocks, trunk, and limbs.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

الجلد يكون صلبًا كلوح الخشب (board-like) وغير منطبع بالضغط (non-pitting)، وملتصقًا تمامًا بما تحته بحيث لا يمكن قرصه أو تحريكه. ينتشر في الفخذين والمؤخرة والجذع والأطراف، مع سلامة نسبية لراحتي اليدين وأخمصي القدمين، وقد يقيد حركة القفص الصدري مهددًا التنفس.

Q4: How Do You Differentiate Sclerema from Its Mimics?

Sclerema vs Subcutaneous Fat Necrosis vs Scleredema vs Edema vs Cellulitis

Condition	Primary Patient Type	Lesion Morphology & Key Distinctions	Prognosis / Complications
Sclerema Neonatorum	Premature / LBW • Critically ill	Diffuse, board-like, non-pitting induration; unpinchable; spared palms/soles.	Poor; strong association with severe systemic illness / high mortality.
Subcutaneous Fat Necrosis	Term or Post-term • Often otherwise well	Discrete, firm nodules or plaques (back, cheeks, buttocks, shoulders).	Good; localized, but may be followed by hypercalcemia.
Scleredema Neonatorum	Neonates	Tissue induration distinctly associated with edema.	Distinct entity; terminology varies in older literature.
Cellulitis	Neonates (localized)	Localized erythema, warmth, swelling, tenderness (can be atypical).	Bacterial infection requiring targeted antibiotics.
Generalized Edema	Neonates (fluid overload)	Causes tissue swelling that produces pitting, lacking board-like firmness.	Depends on underlying renal/cardiac/fluid cause.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

فخ الامتحانات الأكبر: نخر الدهون تحت الجلد (SCFN) يصيب أطفال كاملي النمو (Term) ويظهر كعقد محددة قد يعقبها ارتفاع كالسيوم الدم، بينما التصلب الوليدي (Sclerema) يصيب الخدج المرضى بحالة حرجة ويأتي كتصلب منتشر بدون انطباع بالضغط ونسب وفاته عالية. الوذمة العامة تترك انطباعًا بالضغط (Pitting) بعكس التصلب الخشبي.

Q5: How Is Sclerema Diagnosed & What Does Histopathology Reveal?

Clinical criteria, systemic workups, and biopsy hallmarks

Primary MethodPrimarily clinical; based on diffuse, board-like, non-pitting induration in a severely ill infant.

Immediate PriorityAssess physiological stability and identify underlying sepsis or organ dysfunction.

Systemic WorkupCBC, blood cultures, glucose, electrolytes, metabolic panels, blood gas analysis, organ function tests.

Skin Biopsy RoleUseful when diagnosis is uncertain or differentiation from fat necrosis is required.

Classic HistologyThickening of supporting connective tissue trabeculae in subcutaneous fat.

Inflammation on BiopsyRelatively sparse inflammation and no prominent fat necrosis in the classic pattern.

Biopsy PrecautionNot mandatory in clinically typical cases; must not delay resuscitation or antimicrobial therapy.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

التشخيص يعتمد أولاً على الفحص السريري، والأولوية القصوى لإنعاش الطفل وعلاج الإنتان. إذا أُجريت خزعة جلدية، تُظهر علامة نسيجية كلاسيكية: زيادة سمك الحواجز الضامة (Trabeculae) في الدهون مع قلة الالتهاب وغياب النخر الدهني الواضح. الخزعة ليست إلزامية ويحظر أن تؤخر بدء العلاج.

Q6: How Is Sclerema Managed & What Is the Evidence for Proposed Drugs?

NICU resuscitation, antimicrobial therapy, and controversial interventions

Level of CareMedical emergency requiring immediate admission to a Neonatal Intensive Care Unit (NICU).

Supportive PillarsAppropriate thermal environment, respiratory support, circulatory/perfusion support, fluid/electrolyte & nutritional management.

Antimicrobial RulePrompt cultures followed by empiric antimicrobial therapy for suspected neonatal sepsis without delay.

⚠️ Status of Proposed Therapies: Insufficient Evidence

Proposed TherapiesExchange transfusion, corticosteroids, and IVIG are described in case reports and small series.

Current ConsensusEvidence is insufficient to establish them as universally effective or routine; they must not replace supportive NICU care.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

الحالة طارئة طبية تستوجب التنويم الفوري في العناية المركزة لحديثي الولادة (NICU) للتدفئة ودعم التنفس والدورة الدموية والبدء الفوري بالمضادات الحيوية الوريدية. العلاجات التجريبية مثل تبديل الدم والكورتيزون وIVIG لا تملك أدلة كافية ولا يُعتمد عليها كعلاج روتيني أبدًا.

Q7: What Is the Prognosis of Sclerema Neonatorum?

Mortality drivers, outcome determinants, and prognosis reality

Historical MortalityHistorically associated with high mortality.

High-Risk ProfilePrognosis is worst in premature / LBW infants with sepsis, shock, or multiorgan failure.

Prognosis DriverOutcome depends primarily on the severity of the underlying systemic illness and NICU availability.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

المرض يرتبط تاريخيًا بنسب وفيات عالية جدًا، وتتحدد نجاة الرضيع بمدى شدة المرض الجهازي الكامن (مثل الصدمة الإنتانية أو الفشل التنفسي) وسرعة التدخل في العناية المركزة.

Concept Verification Fill-in Drill

Select the scientifically accurate keyword from each bracketed dropdown

1. Sclerema neonatorum predominantly affects infants, typically developing during the .

2. On physical examination, the characteristic skin finding is diffuse, induration, and the skin .

3. Unlike widespread involvement of the thighs, buttocks, and trunk, the are often relatively spared.

4. In contrast to sclerema neonatorum, subcutaneous fat necrosis of the newborn typically occurs in and may be followed by .

5. Skin biopsy in classic sclerema neonatorum shows with .

6. Interventions such as exchange transfusion, corticosteroids, and IVIG have and must not replace supportive intensive care in the NICU.

Card 1 of 10 • Mastered: 0

DEFINITION

Loading question...

Loading answer...

Board-Style Clinical Examination

Question 1 of 6

Score: 0

High-Yield Timelines, Numbers & Contrasts

Essential metrics extracted directly from the reference

Onset Window

First Week

Typically develops during the first days of life (often within the 1st week) in a critically ill newborn.

Spared Sites

Palms & Soles

Palms and soles are often relatively spared, while thighs, buttocks, trunk, and limbs harden diffusely.

Tissue Pitting

0% Pitting

Non-pitting, board-like consistency; skin cannot be pinched or moved over underlying structures.

Classic Biopsy

Trabeculae

Shows thickened connective tissue trabeculae with sparse inflammation and no prominent fat necrosis.

SCFN Mimic Complication

↑ Calcium

Subcutaneous fat necrosis occurs in term/post-term infants and carries risk of subsequent hypercalcemia.

Evidence for IVIG / Steroids

Insufficient

Exchange transfusion, steroids, and IVIG have insufficient evidence to establish routine efficacy.

Neonatal Induration Sorter Game

Click an item, then click its corresponding diagnostic category

1. Sclerema Neonatorum

2. Subcutaneous Fat Necrosis (SCFN)

3. Scleredema / Fluid Edema / Cellulitis

Exam-Night Ultra-Dense Keyword Matrix

Bare exam anchors for rapid 3-minute pre-test scan

Clinical Question	Bare High-Yield Answer (Exam Anchors)
Target patient profile?	Critically ill, premature, or low-birth-weight newborns.
Typical onset window?	First week of life (often first days).
Pathognomonic skin texture?	Diffuse, board-like, non-pitting induration; tightly bound/unpinchable.
Which body sites are relatively spared?	Palms and soles are often relatively spared.
Major life-threatening functional risks?	Direct interference with respiration and feeding.
Is it caused solely by cold exposure?	NO; it is a sign of critical systemic illness / sepsis.
Classic biopsy findings?	Thickened connective tissue trabeculae; sparse inflammation; NO prominent fat necrosis.
Fat Necrosis (SCFN) vs Sclerema?	SCFN: Term/post-term, discrete nodules/plaques, hypercalcemia risk.
Pitting edema vs Sclerema?	Generalized edema causes pitting; Sclerema is strictly non-pitting.
Primary emergency management?	NICU care: thermal control, respiratory/circulatory support, empiric antibiotics for sepsis.
Status of exchange transfusion / IVIG / steroids?	Insufficient evidence to establish routine efficacy; must not replace NICU supportive care.
Prognosis driver?	High mortality historically; driven by underlying sepsis and multiorgan failure.

💡 ملخص سريع ليلة الامتحان باللغة العربية:

المرضى: خدج وناقصو وزن مرضى بحالة حرجة • وقت الظهور: الأسبوع الأول • ملمس الجلد: متصلب كاللوح، غير منطبع، ملتصق بما تحته • المواقع السليمة: باطن اليدين والقدمين • الخطر التنفسي: يقيد التنفس والرضاعة • الخزعة: زيادة سمك الحواجز الضامة (Trabeculae) بدون نخر دهني واضح • الفارق مع نخر الدهون (SCFN): نخر الدهون يصيب الأطفال كاملي النمو ويحدث عقدًا محددة وفرط كالسيوم • العلاج: عناية مركزة (NICU) ومضادات حيوية للإنتان • الأدوية التجريبية (IVIG والكورتيزون وتبديل الدم): لا دليل كافٍ عليها.

Source References: Sclerema Neonatorum: Clinical Features, Diagnosis, and Management. Incorporating: Zeb A, Darmstadt GL, J Perinatol 2008; DermNet NZ Clinical Reference; Sclerema Neonatorum in a Term Infant (PMC Review); Subcutaneous Fat Necrosis Clinical & Histopathological Correlation (PMC). (October 2026 Edition).

Neonatal Cephalic Pustulosis (NCP): Interactive Clinical Study Tool

2026-10-25T20:52:13.777+00:00

NCP Clinical Mastery Tool

Neonatal Pustular Eruptions: Timing of Onset Spectrum

Q1: What is Neonatal Cephalic Pustulosis (NCP) & How Is It Defined?

Definition, clinical nature, and historical confusion

Condition TypeBenign, self-limiting inflammatory eruption of early infancy.

Typical OnsetDevelops during the first few weeks of life (most commonly first 2 to 3 weeks).

Lesion MorphologySmall inflammatory papules and pustules, occasionally with a faint erythematous halo.

Anatomic SitesPredominantly the face (cheeks, forehead, chin); scalp, neck, and upper chest may be involved.

Historical GroupingTraditionally grouped with neonatal acne, but distinct because it lacks comedones.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

بثار الرأس الوليدي (NCP) هو طفح التهابي حميد ومحدد لذاته يصيب الرضع في أول أسبوعين إلى ثلاثة أسابيع من العمر. يظهر على الوجه (الخدين والجبهة والذقن) وفروة الرأس والرقبة، ويمتاز بغياب الزؤان (Comedones) وهو ما يفرقه عن حب الشباب الوليدي الحقيقي.

Q2: What Causes NCP & What Is the "Malassezia Controversy"?

Etiology, fungal associations, and scientific debate

Exact MechanismNot fully established; underlying cause remains incompletely understood.

Fungal SuspectsPossible association with Malassezia furfur and Malassezia sympodialis.

The HypothesisDetection of Malassezia in pustular material suggested it may trigger inflammatory responses.

The ControversyYeasts normally colonize human skin; presence does NOT prove causation or mandate antifungal therapy.

⚠️ Scientific Nuance: Colonization vs True Pathogen

Microscopy LimitFinding Malassezia supports an association but cannot independently confirm diagnosis because it is normal commensal flora.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

السبب الدقيق غير محسوم بالكامل. توجد فرضية تربطه بخمائر الملاسيزية (Malassezia furfur و Malassezia sympodialis) لوجودها في البثرات، لكن الأمر مثير للجدل لأن هذه الخمائر جزء طبيعي من فلورا جلد الإنسان، ومجرد وجودها لا يثبت أنها السبب المباشر للمرض.

Q3: What Is the Golden Rule & How Is It Distinguished from Mimics?

The 'No Comedone' hallmark and comparison matrix

Pathognomonic ClueAbsence of open & closed comedones is the key feature separating NCP from comedonal acne.

Systemic HealthInfants are otherwise well; feeds normally, zero systemic symptoms from skin.

Condition	Timing of Onset	Key Distinguishing Features
Neonatal Cephalic Pustulosis (NCP)	Weeks 2–3	Small papules/pustules on face/scalp; NO comedones; infant well.
Neonatal Acne	Weeks after birth	May include open or closed comedones (blackheads/whiteheads).
Erythema Toxicum Neonatorum (ETN)	First days (24–72h)	Erythematous macules with pustules (flea-bitten halo); involves trunk and limbs.
Transient Neonatal Pustular Melanosis (TNPM)	Present at birth	Fragile pustules rupture easily → leave pigmented macules + scale collarette.
Miliaria	Variable / heat	Due to sweat duct obstruction; papules/vesicles in warm, occluded sites.
Bacterial Folliculitis / Impetigo	Variable	Pustules, erosions, honey-colored crusting; requires bacterial consideration.
Neonatal Herpes Simplex (HSV)	Variable / urgent	Grouped vesicles, erosions, systemic illness; requires urgent evaluation.

MNEMONIC: THE "N-C-P" RULE

• No Comedones (Open/closed comedones are totally absent).
• Cephalic predilection (Cheeks, forehead, chin, scalp, neck).
• Period: 2–3 weeks of life (Benign, spontaneous resolution in weeks/months).

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

القاعدة الذهبية: حب الشباب الوليدي الحقيقي يحتوي على رؤوس بيضاء أو سوداء (Comedones)، بينما بثار الرأس الوليدي (NCP) يخلو منها تمامًا. في التشخيص التفريقي: (TNPM) يظهر عند الولادة ويترك تصبغات، و(ETN) يظهر في الأيام الأولى على الجذع بهالة حمراء، بينما الهربس يظهر بحويصلات متجمعة وتدهور عام ويعد طارئًا طبيًا.

Q4: How Is NCP Diagnosed & When Are Tests Necessary?

Clinical criteria, KOH prep, microscopy, and infectious workups

Primary MethodClinical diagnosis based on age, cephalic distribution, and absence of comedones.

Routine LabsUnnecessary in typical presentations where the newborn is otherwise well.

KOH ExaminationMicroscopic prep of pustule material may demonstrate fungal elements.

Staining / SmearDirect microscopy characterizes inflammatory cells and screens for organisms.

Infectious WorkupBacterial or viral testing ordered only if lesions or clinical state suggest infection.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

التشخيص سريري بحت ولا يتطلب تحاليل روتينية إذا كان الرضيع بصحة جيدة. نلجأ للفحص المجهري بـ (KOH) أو صبغات البكتيريا والفيروسات فقط عند الشك بوجود عدوى خطيرة أو إذا كان مظهر الطفح غير تقليدي.

Q5: What Is the Management Protocol & What Drugs Are Contraindicated?

Supportive care, selective antifungals, and contraindicated medications

First-Line CareReassurance & observation; spontaneous resolution is expected.

Supportive HygieneGentle cleansing with water or mild fragrance-free cleanser.

Strictly AvoidFriction, squeezing, manipulation, and unnecessary irritating topicals.

Topical AntifungalKetoconazole considered selectively (persistent or cosmetically prominent), not routinely.

NOT IndicatedTopical/oral antibiotics and conventional acne medications are not indicated for uncomplicated NCP.

PrognosisExcellent; resolves over weeks to months with no permanent scarring.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

العلاج الأساسي هو الطمأنة والمراقبة مع تنظيف لطيف بالماء أو غسول خفيف خالٍ من العطور دون عصر أو فرك. يمكن للطبيب التفكير بدهان الكيتوكونازول الموضعي بشكل انتقائي فقط في الحالات المستمرة أو المشوهة، وتمنع المضادات الحيوية وأدوية حب الشباب التقليدية منعًا باتًا لعدم الحاجة إليها وحساسية جلد الرضيع.

Q6: What Are the Red Flags That Mandate Urgent Medical Assessment?

Signs that rule OUT simple benign cephalic pustulosis

Vital Sign Red FlagsFever or abnormally low body temperature (hypothermia).

Behavioral SignsPoor feeding, unusual lethargy, or reduced responsiveness.

Cutaneous Red FlagsGrouped vesicles, skin erosions, or rapidly spreading lesions.

Epidermal Red FlagsExtensive skin peeling or a generally unwell infant appearance.

Clinical ActionNever delay evaluation for bacterial infection or HSV while waiting for rash to evolve.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

لا يجوز افتراض سلامة أي طفح بثري عند الرضيع إذا ترافق مع: حرارة أو هبوط حرارة، خمول ونعاس غير طبيعي، ضعف رضاعة، حويصلات متجمعة، تآكلات جلدية، أو تقشر واسع. هذه علامات خطر تتطلب تقييمًا طبيًا فوريًا لاستبعاد العدوى البكتيرية والهربس.

Concept Verification Drill

Select the scientifically accurate keyword from each bracketed dropdown

1. Neonatal cephalic pustulosis characteristically appears during the and predominantly affects the cheeks, forehead, chin, scalp, and neck.

2. The primary clinical hallmark that distinguishes NCP from comedonal neonatal acne is the complete .

3. A proposed fungal association involves , though its exact role is controversial because it normally colonizes human skin.

4. Unlike TNPM, which is present at birth, and ETN, which appears in the first days on the trunk, uncomplicated NCP is primarily managed with .

5. If the eruption is persistent or cosmetically prominent, a clinician may selectively consider .

6. The appearance of grouped vesicles, poor feeding, or constitutes a red flag mandating prompt medical evaluation for serious infection.

Card 1 of 10 • Mastered: 0

DEFINITION

Loading question...

Loading answer...

Clinical Board-Style Examination

Question 1 of 6

Score: 0

High-Yield Timelines, Numbers & Distinctions

Essential clinical metrics extracted strictly from the reference

Typical Onset

Weeks 2–3

Most commonly appears during the first 2 to 3 weeks after birth (first few weeks).

Comedone Count

Zero (0)

Open and closed comedones are completely absent, distinguishing it from comedonal acne.

Resolution Time

Weeks–Months

Spontaneous resolution over several weeks to a few months without permanent scarring.

Malassezia Species

2 Yeasts

M. furfur and M. sympodialis; proposed association remains controversial.

Selective Agent

Ketoconazole

Topical antifungal considered only if persistent or cosmetically prominent; not routine.

Scarring Risk

0% Scars

Uncomplicated NCP has an excellent prognosis; permanent scarring is not expected.

Neonatal Eruption Classifier

Click an item, then click its matching clinical category

1. Benign NCP (Typical)

2. Other Benign Mimics (ETN/TNPM/Acne)

3. Urgent Red Flags (Infection/HSV)

Exam-Night Ultra-Dense Keyword Matrix

Bare exam anchors for rapid 3-minute pre-test scan

Clinical Question	Bare High-Yield Answer (Exam Anchors)
Typical onset window?	First 2 to 3 weeks of life (first few weeks).
Cardinal feature absent?	COMEDONES (open and closed comedones are absent).
Anatomic distribution?	Cephalic: cheeks, forehead, chin, scalp, neck, ± upper chest.
Associated fungal species?	Malassezia furfur & Malassezia sympodialis (controversial).
Does Malassezia prove causality?	NO; it is part of normal skin flora colonization.
Routine laboratory need?	Unnecessary in typical cases when infant is well.
First-line management?	Reassurance & observation + gentle cleansing with water.
Selective pharmacotherapy?	Topical ketoconazole (only if persistent/prominent).
Are antibiotics/acne meds indicated?	NO; not indicated for uncomplicated NCP.
Long-term scarring prognosis?	Zero permanent scarring; resolves spontaneously in weeks to months.
Major urgent mimics to rule out?	Neonatal HSV (grouped vesicles/erosions) and bacterial infections.
Systemic Red Flags?	Fever, hypothermia, lethargy, poor feeding, skin erosions.

💡 ملخص سريع باللغة العربية:

الظهور: الأسبوع 2-3 من العمر • العلامة الفارقة: غياب الزؤان (Comedones) تمامًا • التوزيع: الخدان والجبهة والذقن وفروة الرأس • الفطر المرتبط: ملاسيزية (دورها غير مؤكد) • التحاليل: غير ضرورية إذا كان الطفل بصحة جيدة • العلاج: طمأنة وغسيل لطيف بالماء فقط؛ والكيتوكونازول الموضعي انتقائي للحالات المعندة • تمنع أدوية حب الشباب والمضادات • التوقع: شفاء تام بلا ندبات • علامات الخطر: حرارة أو هبوط حرارة، خمول، ضعف رضاعة، وحويصلات متجمعة (اشتباه هربس).

Source References: Neonatal Cephalic Pustulosis: Clinical Features, Diagnosis, and Management. Incorporating: DermNet NZ; Chang MW et al., Pediatr Dermatol, 2024; Neonatal Pustular Dermatosis Review (PMC); University of Utah Dept of Dermatology. (October 2026 Edition).

Erythema Toxicum Neonatorum (ETN): Interactive Clinical Study Tool

2026-10-22T22:26:32.373+00:00

Erythema Toxicum Neonatorum

ETN study tool · English terms + Arabic helper notes · works offline · keys: [ ] switch mode

Source: DermNet NZ, Toxic erythema of the newborn · Ghosh S, Indian J Dermatol 2015;60(2):211 · Reginatto et al, An Bras Dermatol 2016;91(2):124–134 · Morgan et al, Cutis 2009;83(1):13–16 · StatPearls, Erythema Toxicum (NCBI Bookshelf). Source pack used Oct 2026. Blue-green boxes are Arabic helper notes, not part of the source. Study aid only, not for clinical decisions.

2026-10-22T13:31:50.204+00:00

🔍 What is the exact clinical definition of TNPM?

Classification A benign, self-limiting pustular dermatosis of newborns.

Lesion Type Superficial, fragile pustules (usually 1–3 mm).

Key Feature Lacks a surrounding erythematous halo (skin around pustule is normal).

Evolution Resolves leaving transient hyperpigmented macules with thin collarette of scale.

Infectious? Strictly noninfectious; no specific treatment required when diagnosis is secure.

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
الميلانوز البثري الوليدي العابر (TNPM) طفح جلدي حميد يزول من تلقاء نفسه، يولد الطفل به غالبًا. أهم علامة تميزه بالعين المجردة أن البثور سطحية وسريعة الانفجار، وتقع على جلد طبيعي دون هالة حمراء ملتهبة تحيط بها، وتترك مكانها بقعًا داكنة محاطة بقشور دقيقة.

📊 What are the epidemiological & etiologic facts?

Prevalence Reported range: 0.2% to 4% (varies by study and population; interpret in context).

Skin Types Reported more frequently in darker skin pigmentation (occurs in all skin types).

Etiology Cause remains unknown; no infectious etiology established.

ETN Relation Conventionally distinct entities, though some clinical and histopathological overlap exists.

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
نسبة حدوثه تتراوح بين 0.2% و 4% حسب التعداد السكاني المدروس، وهو أكثر شيوعًا عند المواليد ذوي البشرة الداكنة مع إمكانية حدوثه في كافة أنواع البشرة. سببه الدقيق غير معروف، ويُعتبر طبيًا كيانًا منفصلًا عن الطفح السمي الوليدي (ETN) رغم وجود بعض التشابه.

⏰ When does it appear and where is it located?

Onset Typically present at birth (ruptured in utero = presents only as macules).

Head & Neck Forehead, chin, and neck.

Body Trunk, back, and buttocks.

Acral Occasionally palms and soles (distribution varies between infants).

Systemic Newborn is generally well (normal appearance does NOT exclude infection).

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
البثور تظهر منذ لحظة الولادة مباشرة، وأحيانًا تنفجر قبل الولادة داخل الرحم فيولد الطفل فقط ببقع بنية. تتركز في الجبهة والذقن والرقبة والظهر والأرداف، وقد تصيب راحتي اليدين وأخمصي القدمين. الطفل يكون بصحة عامة جيدة دون حرارة أو خمول.

🔬 What do histology and laboratory smears show?

Routine Labs Not required in typical presentations.

Pustule Smear Neutrophils predominate on cytology.

Histology Superficial intraepidermal or subcorneal pustules filled with neutrophils.

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
التشخيص سريري بالأساس ولا يتطلب فحوصات دم أو خزعة عادية. وإذا فُحصت محتويات البثرة تحت المجهر نجد سيطرة واضحة للعدلات (Neutrophils) داخل البشرة السطحية أو تحت الطبقة القرنية.

⏳ What is the timeline and long-term prognosis?

Pustule Life Pustules disappear within a few days.

Pigment Life Fades over several weeks to ~3 months (occasionally longer).

Permanent Scar No permanent scarring expected; prognosis is excellent.

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
البثور الصديدية تختفي في غضون أيام قليلة جدًا، بينما التصبغات البنية المتبقية تزول تدريجيًا خلال أسابيع إلى ثلاثة أشهر تقريبًا دون أن تترك أي ندبات دائمة إطلاقًا.

💊 How is it managed and when should we worry?

Rx Regimen No specific treatment (reassurance + gentle skin care + observation).

Contraindicated No antibiotics, antifungals, or topical steroids indicated solely for TNPM.

Do Not Avoid manipulating or popping pustules.

Red Flags Fever, hypothermia, lethargy, poor feeding, grouped vesicles, extensive erosions, mucosa.

Crucial Rule Absence of fever does NOT reliably exclude neonatal infection!

💡 توضيح وشرح مبسط (إضافة تعليمية مساعدة)
العلاج هو الطمأنة فقط؛ يُمنع استخدام المضادات الحيوية أو الفطرية أو الكورتيزون بدون داعٍ، ويُمنع عصر البثور. علامات الخطر التي تستوجب التدخل العاجل: الحرارة، انخفاض الحرارة، الخمول، ضعف الرضاعة، أو وجود حويصلات متجمعة وقروح بالفم.

🖼️ Visual Comparison: Halo Presence (ETN vs. TNPM)

📈 Evolution Stages: 3-Phase Progression

💡 التسلسل الزمني بالرسم
المرحلة 1: بثور سطحية عند الولادة (1-3 مم).
المرحلة 2: تمزق خلال أيام وتخلف قشرة دقيقة محيطية (Collarette of scale).
المرحلة 3: بقع بنية تصبغية تتلاشى تدريجيًا على مدى عدة أسابيع إلى 3 أشهر تقريبًا.

🧠 High-Yield Mnemonic: "NO-HALO"

NNeutrophils on smear & intraepidermal pustules.

OOnset at birth (classic presentation).

HHyperpigmented macules with collarette of scale.

AAbsence of surrounding erythematous halo.

LLow/No intervention (benign, self-limiting, reassurance).

OOverall well newborn (pigment resolves ~3 months).

✏️ Interactive Bracket Selector: Test Knowledge Inside Lines

Choose the exact factual option from the dropdowns inside each clinical line, then click "Verify Choices".

1. TNPM pustules characteristically erythematous halo.

2. Cytology of the pustular contents demonstrates predominantly within the fluid.

3. Unlike Erythema Toxicum, TNPM lesions are characteristically as the classic pattern.

4. The residual hyperpigmented macules usually fade gradually over .

5. For typical uncomplicated TNPM, recommended treatment is .

Card 1 of 6 Click card to flip

QUESTION

What is the defining halo feature of TNPM pustules?

💡 توضيح مساعد للبطاقة
البثور تفتقر تمامًا إلى أي هالة حمراء ملتهبة تحيط بها، مما يميزها فورًا عن الإريثيما توكسيكم.

⚖️ Clinical Differential Sorter: Match Condition to Feature

Click a clinical feature below to classify it under the correct neonatal dermatosis.

TNPM

Erythema Toxicum Neonatorum

Neonatal HSV

Congenital Candidiasis

Miliaria Pustulosa

Neonatal Cephalic Pustulosis

📝 Board-Style Multiple Choice Exam

1. A term infant is examined 30 minutes after delivery. There are 2-mm superficial, easily rupturing pustules on the chin and back without surrounding erythema. What is the most expected cytologic finding from a pustule smear?

2. An anxious mother notices that her newborn's facial pustules have ruptured and turned into small brown spots. What should you explain regarding their resolution?

3. Which of the following features most reliably distinguishes TNPM from Erythema Toxicum Neonatorum (ETN)?

4. When is immediate evaluation for systemic or neonatal infection mandatory in a baby with pustules?

⚡ Rapid Recall Cheat Sheet (Exam Night High-Yields)

Prevalence0.2% – 4% (varies by studied population; more frequent in darker skin).

EtiologyUnknown • Noninfectious • Benign • Self-limiting.

Primary Sign1–3 mm superficial pustules • NO erythematous halo.

OnsetPresent at birth (or ruptures in utero leaving macules only).

SitesForehead, chin, neck, trunk, buttocks, back • Palms & soles occasionally.

EvolutionPustule → Rupture + collarette of scale → Hyperpigmented macule.

CytologyPredominantly Neutrophils (intraepidermal / subcorneal).

TimelinePustules: few days • Macules: weeks to ~3 months • No scarring.

TreatmentNONE • Gentle skin care • Reassurance • Avoid popping.

Red FlagsFever / Hypothermia • Lethargy • Poor feeding • Grouped vesicles • Mucosal lesions.

Vital RuleAbsence of fever does NOT exclude neonatal infection!

Darier Disease: High-Yield Interactive Clinical Study & Mastery Tool

2026-10-09T17:56:27.278+00:00

Darier Disease Study App

Molecular Mechanism: SERCA2 Pump Defect & Cellular Disruption

Q1: What is Darier disease, its synonyms, and its underlying defect?

Eponyms, gene mutation, and inheritance pattern

SynonymsDarier–White disease • Dyskeratosis follicularis.

Core MutationPathogenic variants in ATP2A2 encoding the SERCA2 pump.

PathophysiologyDisrupted calcium transport impairs intracellular Ca2+ regulation, cell-cell adhesion, and differentiation.

InheritanceAutosomal dominant; variable expression; 50% transmission risk per pregnancy.

Mosaic VariantSegmental lesions follow Blaschko's lines via postzygotic mosaicism (often no family history).

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

مرض دارييه (دارييه-وايت) ناتج عن طفرة سائدة في جين (ATP2A2) الذي يشفر مضخة الكالسيوم (SERCA2). تعطل نقل الكالسيوم يؤدي لخلل التصاق خلايا البشرة ببعضها وتفككها وظهور تقرن شاذ، وينتقل بنسبة 50% للأبناء.

Q2: What are the pathognomonic clinical hallmarks (Nails, Skin, Mucosa)?

Diagnostic features in seborrheic and acral zones

Nail Pathognomonic Architecture

Skin PapulesFirm, greasy, hyperkeratotic papules; skin-colored to yellowish/reddish-brown; rough/crusted.

DistributionSeborrheic & flexural areas: scalp, forehead, temples, ears, neck, central chest, back, axillae, groin.

Nail HallmarksLongitudinal red & white streaks with V-shaped distal notching and subungual hyperkeratosis.

Palms & SolesMultiple small palmar pits, punctate keratoses, flat wart-like papules on dorsal hands.

Oral MucosaSmall whitish papules producing a cobblestone appearance (hard palate, buccal mucosa).

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

حطاطات دهنية متقرنة في المناطق الصدرية والوجه وثنايا الجسم برائحة كريهة. الدليل التشخيصي الأوضح في الفحص هو الأظافر: خطوط حمراء وبيضاء طولية وثلم على شكل حرف V عند الحافة الحرة، مع وجود حفر نقطية في باطن اليد ومظهر الحصى في الفم.

Q3: What are the pathognomonic findings on skin biopsy?

Suprabasal acantholysis, dyskeratosis, corps ronds, and grains

Microscopic PatternSuprabasal acantholytic dyskeratosis.

Corps RondsEnlarged, rounded dyskeratotic cells with eosinophilic cytoplasm in the spinous/granular layers.

GrainsSmall, flattened dyskeratotic cells with dense nuclei in the upper epidermis/stratum corneum.

Lacunae & VilliSuprabasal clefts immediately above basal cells; dermal villi project into spaces.

MNEMONIC: HISTOLOGY LAYERS

• Corps Ronds = Central (Spinous/Granular), Round with halo.
• Grains = Ground on top (Stratum corneum), Flat and small.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

الخزعة تظهر تفككًا وانحلالًا شوكيًا فوق الطبقة القاعدية (Acantholysis) وخلايا متقرنة شاذة: الأجسام المستديرة (Corps ronds) في الطبقة الشائكة، والحبيبات الصغيرة (Grains) في الطبقة القرنية السطحية.

Q4: How to differentiate Darier disease from clinical mimics?

Hailey–Hailey vs Grover vs Darier

Condition	Clinical Distinction	Histopathological Key
Darier Disease	Seborrheic greasy papules; V-notched nails; palmar pits	Suprabasal acantholytic dyskeratosis with corps ronds & grains
Hailey–Hailey	Painful flexural erosions/maceration; no nail streaks	Widespread acantholysis: 'dilapidated brick-wall' appearance
Grover Disease	Pruritic trunk papules in older adults; acquired & transient	Focal acantholysis; lacks inherited nail signs and family history
Acrokeratosis (Hopf)	Flat wart-like papules on dorsal hands and feet	Allelic ATP2A2 phenotype; lacks widespread seborrheic plaques

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

أهم فارق: مرض هيلي-هيلي يصيب الثنايا لكنه يظهر بالمجهر كـ "جدار طوب متهدم" (dilapidated brick-wall) ولا تصحبه تغيرات أظافر دارييه. أما مرض غروفر فهو عارض ومكتسب لدى كبار السن.

Q5: What are the systemic retinoid rules and safety washouts?

Acitretin vs Isotretinoin: Washout times, alcohol restrictions, and study data

Acitretin WashoutAvoid pregnancy & blood donation for at least 3 years post-stopping (US labeling).

Acitretin & AlcoholStrictly avoid alcohol during therapy and for 2 months afterward (prevents conversion to etretinate).

Isotretinoin WashoutAvoid pregnancy & blood donation for at least 1 month post-stopping; avoid tetracyclines.

Isotretinoin DataIn 104 patients: ~70% improved at 1–4 wks; 98 of 104 improved at 16 wks; 11 discontinued due to toxicity.

⚠️ Source Nuance / Study Flaw: Topical Calcipotriol Aggravation

Clinical WarningTopical calcipotriol can aggravate Darier disease and trigger severe irritation.

1995 Study Discrepancy8 patients were withdrawn due to irritation/worsening: abstract reported this as 8 of 12 patients, but the enrolled population description listed 11 patients.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

الأسيتريتين يتطلب منع الحمل والتبرع بالدم لمدة 3 سنوات بعد إيقافه ومنع الكحول لمدة شهرين. الآيزوتريتينوين يتطلب شهرًا واحدًا فقط ويمنع جمعه مع التتراسيكلين. احذر: دهان الكالسيبوتريول قد يزيد المرض سوءًا.

Q6: What complications, infections, and oncologic risks occur?

Eczema herpeticum emergency and keratinocyte carcinoma

Viral EmergencyEczema herpeticum (Kaposi varicelliform): HSV causes punched-out erosions & fevers.

Antiviral ActionRequires urgent systemic acyclovir; do not delay treatment awaiting lab confirmation.

Bacterial / FungalStaphylococcus aureus (honey crusts/malodor); Candida in macerated flexural folds.

Malignancy Risk2024 Swedish nationwide study revealed an increased risk of keratinocyte carcinoma.

💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):

عدوى فيروس الهربس البسيط تسبب طفح إكزيما هربسية وهي حالة طارئة تعالج بالأسيكلوفير فورًا دون انتظار التحاليل. أظهرت دراسة سويدية عام 2024 زيادة خطر الإصابة بسرطان الخلايا الكيراتينية في الجلد.

Concept Verification Fill-in Drill

Select the accurate scientific option from each bracketed dropdown

1. Darier disease is caused by pathogenic variants in which encodes the .

2. A pathognomonic nail finding is longitudinal erythronychia or leukonychia combined with .

3. Under the microscope, enlarged rounded dyskeratotic cells in spinous/granular layers are termed , while small flattened cells in the stratum corneum are called .

4. Patients taking oral acitretin must avoid pregnancy and blood donation for at least post-treatment, and avoid alcohol for .

5. For oral isotretinoin, the required post-treatment contraception washout period is and it should never be combined with .

6. A flare with widespread punched-out erosions signifies eczema herpeticum, requiring urgent .

Card 1 of 14 • Mastered: 0

GENETICS

Question loading...

Answer loading...

Board-Style Clinical Examination

Question 1 of 8

Score: 0

Question...

High-Yield Metrics, Washouts, & Trial Numbers

Essential cutoffs and study discrepancies from the clinical report

Acitretin Washout

3 Years

Pregnancy & blood donation prohibited during treatment and for ≥3 years post-stopping.

Acitretin Alcohol

2 Months

Alcohol prohibited during treatment and for 2 months after to prevent etretinate formation.

Isotretinoin Washout

1 Month

Pregnancy & blood donation avoided during therapy and for ≥1 month post-treatment.

Transmission Risk

50% Probability

Autosomal dominant risk per child of an affected individual with a constitutional variant.

Calcipotriol Discrepancy

8 / 12 vs 11

1995 trial: 8 withdrawn; abstract states 8 of 12, but text lists 11 enrolled patients.

Isotretinoin Response

70% → 98 / 104

~70% improved at 1–4 wks; 98 of 104 improved at 16 wks; 11 discontinued due to toxicity.

Clinical Entity Classifier

Click on an item, then click its matching bucket (or drag & drop)

1. Histology & Cells

2. Clinical Hallmarks

3. Retinoid Washouts

4. Investigational Drugs

Exam-Night Ultra-Dense Keyword Matrix

Bare exam anchors for rapid 5-minute pre-test scan

Clinical Question	Bare High-Yield Answer
Gene & Defective Pump?	ATP2A2 → SERCA2 (Sarco/ER Ca2+ pump).
Inheritance & Risk?	Autosomal dominant; 50% probability per pregnancy.
Pathognomonic Nails?	Red/white streaks + V-shaped distal notching.
Corps Ronds vs Grains?	Corps ronds = spinous/granular, round, halo. Grains = corneum, flat, dense.
Acitretin Washouts?	≥3 years for pregnancy/blood donation; 2 months for alcohol.
Isotretinoin Washout?	≥1 month for pregnancy/blood donation; avoid tetracyclines.
Viral Emergency?	Eczema herpeticum (HSV) → prompt systemic acyclovir.
Secondary Malignancy?	Increased risk of keratinocyte carcinoma (2024 Swedish study).
Preclinical Ca2+ Drug?	Dantrolene (corrects cell adhesion in preclinical SERCA2 models).

💡 ملخص سريع باللغة العربية:

الجين: ATP2A2 ومضخة SERCA2 • الوراثة: سائدة 50% • الأظافر: خطوط حمراء وبيضاء مع ثلم حرف V • الهستولوجيا: انحلال شوكي؛ كورب روند في الطبقة الشائكة وحبيبات في القرنية • الأسيتريتين: منع حمل 3 سنوات وكحول شهرين • الآيزوتريتينوين: منع حمل شهر وممنوع مع التتراسيكلين • الهربس يسبب إكزيما هربسية وطوارئ أسيكلوفير • زيادة خطر سرطان الخلايا الكيراتينية.

Source References: Diagnosis and Treatment of Darier Disease: A Comprehensive Medical Report (Prepared October 09, 2026). Incorporating consensus guidelines (Has et al., 2026; Ettinger et al., 2025; Hanna et al., 2022; DermNet NZ; Burge & Wilkinson, 1992; Inci et al., 2024; Hunt et al., 2024; DailyMed Acitretin & Isotretinoin).

Vitiligo Treatment Options: Interactive Study Guide

2026-10-09T06:15:23.451+00:00

Vitiligo — Treatment Options

Study tool · source: Oct 2026 review · works offline

Click the tool once to enable keys: R L C Q D S F switch mode · T theme · 1–4 choose · Enter check/next · Space flip · ← not yet · → got it

Sources (compiled Oct 2026): International Vitiligo Task Force incl. 2026 Consensus on Severity and Relapse; Canadian Consensus Guidelines 2025; Japanese Vitiligo Guideline 2026; FDA and EMA ruxolitinib cream product information; NEJM TRuE-V1/TRuE-V2; JEADV 2026 long-term data; IADVL surgical consensus 2024–2025. The supplied source text ends mid-way through depigmentation therapy (monobenzone), so that section is incomplete. Educational use only — not clinical advice. Arabic notes are study aids, not part of the source.

Idiopathic Guttate Hypomelanosis: Interactive Study Guide

2026-09-20T23:27:11.928+00:00

LabelCraft: Pharmaceutical Labeling Text Drafting Tool

2026-07-28T18:06:30.385+00:00

LabelCraft

An offline reference tool for drafting pharmaceutical labeling text from a curated phrase library.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

LabelCraft is an offline reference tool for drafting pharmaceutical labeling text. It provides a curated library of 211 phrase templates spanning 20 label-content categories — including dosage and administration, storage and handling, pregnancy and lactation, pediatric and geriatric use, renal/hepatic impairment, drug interactions, contraindications, warnings, boxed warnings, adverse reactions, overdose management, OTC Drug Facts panels, Schedule II controlled-substance labeling, and biologics/biosimilars. It is intended for regulatory affairs professionals, pharmaceutical labeling specialists, and students learning labeling conventions who need a starting point for assembling draft label text before formal review.

Users browse or search the phrase library, add relevant phrases to a draft document, and reorder them into sections using drag-and-drop or one-click auto-sort. Five quick-load templates (Package Insert, Carton Label, Container Label, CII Label, OTC Drug Facts ) pre-populate a starting phrase set for common label types. Each phrase is written as a fill-in-the-blank template with bracketed placeholders (e.g., [Product name], [X mg]) and includes its regulatory source citation (FDA, USP, or CFR reference). The finished draft can be copied as plain text, a numbered list, or Word-formatted rich text, or printed directly from the browser.

Features & Functions

Library of 211 pre-written pharmaceutical labeling phrases across 20 categories
Search matches phrase text, category/subcategory label, and the citation note all at once — not just one field
Five one-click quick-load templates that pre-populate a starting phrase set: Package Insert, Carton Label, Container Label, CII (Schedule II) Label, and OTC Drug Facts
Click any phrase to add it to a draft document assembled on the same screen
Drag-and-drop reordering of phrases in the draft document, with touch support for mobile
One-click "auto-sort" restores draft phrases to their original library order
Insert custom section headers/separators anywhere in the draft document
Remove any individual phrase or separator from the draft with one click
Live phrase count of the current draft
Warns before copying if the draft still contains unfilled bracket placeholders (e.g. [X] or [Product name])
Three copy-out formats: Plain text, Numbered list, and Word-formatted (rich text)
Direct browser printing of the assembled document
Mobile-friendly tabbed layout (Categories / Phrases / Document) in addition to the desktop 3-panel view

How to Use This Tool

Browse phrase categories in the left panel, or use the search box to find phrases by keyword, category, or citation
Click a category to filter the phrase library, or select "All" to see everything
Click the "+" button on any phrase to add it to your draft document
Optionally, use a quick-load template (Package Insert, Carton Label, Container, CII Label, or OTC Drug Facts ) to start with a pre-selected set of phrases
In the document panel, drag phrases to reorder them, or click "Auto-Sort" to restore library order
Add section separators to organize the document into labeled parts
Remove any phrase you don't need
Copy the document as Plain text, a Numbered list, or Word-formatted text — or print it directly
Review and complete every bracketed placeholder, and verify all content against current official sources before real-world use

Technical Specifications

Format	Single HTML file
File Size	~89.5 KB
Compatibility	Current versions of Chrome, Edge, Safari, Firefox
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.1
Last Updated	July 20, 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Regulatory affairs professionals and pharmaceutical labeling specialists drafting label text
Students or trainees learning pharmaceutical labeling conventions and terminology
Reference during the labeling drafting/review process, prior to formal regulatory submission

NOT Designed For:

Final, submission-ready regulatory labeling without professional review
Patient-facing medical or dosing advice
Clinical decision-making or patient care
Sole source for a specific product's approved labeling — always verify against the current official source
Controlled-substance or high-alert medication labeling without dedicated pharmacist/regulatory sign-off

Quality & Compliance

This tool includes 12 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all data stays on your device (browser local storage only)

Reliability & Compatibility:

Compatible with current evergreen browsers (Chrome, Edge, Safari, Firefox)
Lightweight file (~89.5 KB) — opens instantly
Clipboard copy includes an automatic fallback if the browser blocks the primary copy method
Keyboard-accessible navigation with visible focus indicators throughout

Sources & Transparency:

Every phrase includes its regulatory source citation (FDA/USP/CFR) directly in the tool
Version number and last-updated date shown in the tool
States clearly that content is static and must be verified against current official sources

Scope & Limitations:

States the jurisdiction the content is written for, with a warning that other countries' requirements differ
Shows specific examples of what NOT to use this tool for
Warns before copying if a phrase still has an unfilled placeholder

Validation Process:

This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal or internal organizational use
Reference during professional labeling drafting
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Provided "as-is" for reference purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.

Our Fair Price Philosophy

We've enabled the 'Pay What You Want' option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.

Your Feedback Matters

We are constantly working to improve our tools. After using LabelCraft, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get LabelCraft Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start drafting pharmaceutical labels offline.

Download The Tool

CrCl Trainer: Cockcroft-Gault Creatinine Clearance Calculator

2026-07-28T17:46:10.235+00:00

CrCl Trainer

An offline educational calculator for practicing the Cockcroft-Gault creatinine clearance calculation.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

CrCl Trainer is an educational tool for learning and practicing the Cockcroft-Gault (1976 ) creatinine clearance calculation, including correct weight selection (Actual, Ideal, or Adjusted Body Weight). It is designed for pharmacy, nursing, and medical students, as well as healthcare educators teaching renal dosing methodology. It addresses the need for repeated, low-stakes practice with this specific calculation before applying it in supervised clinical settings.

The user enters patient parameters (age, sex, height, weight, serum creatinine) either through 25 built-in practice cases or free-form Manual Entry, in either metric or imperial units. The tool calculates estimated creatinine clearance (mL/min) using the Cockcroft-Gault 1976 equation, applies Devine (1974) Ideal Body Weight and Adjusted Body Weight (0.4 correction factor) selection logic based on the %IBW ratio, and displays the result alongside its educational KDIGO 2012/2024 GFR category label, the calculation assumptions made, and the reasoning behind which weight was used.

Features & Functions

Two modes: Practice Cases (guided scenarios) and Manual Entry (free-form calculation)
25 built-in practice cases with varied patient scenarios
Check Answer, Show Answer, Next Case, and Random Case navigation in Practice mode
Running accuracy tracker for your last 10 attempted cases, with a progress bar
Automatic weight-selection logic (Actual vs. Ideal vs. Adjusted Body Weight) based on the %IBW ratio, with the reason shown alongside the result
Educational KDIGO GFR category label shown with each result
Calculation assumptions displayed alongside every result
Unit toggle for height (cm/in), weight (kg/lbs), and serum creatinine (mg/dL/µmol/L), with automatic conversion
Contextual info-icon tooltips explaining inputs and methodology throughout
Bio-range input validation (flags physiologically implausible values before calculating)
Automatic detection and blocking of accidental entry of sensitive personal information (SSN, phone, email, credit card, medical record number, and long ID-number patterns)
Source citations (with PMID/DOI where applicable) shown directly in the tool
Version number and last-updated date displayed in the tool's footer

How to Use This Tool

Read the notice screen and confirm you understand the tool's educational scope
Choose a mode: Practice Cases or Manual Entry
In Practice Cases: review the scenario shown, enter your calculated CrCl, then select Check Answer (to see if you're correct ) or Show Answer (to reveal it directly); use Next Case or Random Case to continue
In Manual Entry: enter age, sex, height, weight, and serum creatinine (switching units if needed), then select Calculate
Review the result, the KDIGO educational category, the weight-selection reasoning, and the listed assumptions
Select Reset to clear Manual Entry fields and start over

Technical Specifications

Format	Single HTML file
File Size	~101 KB
Compatibility	Modern versions of Chrome, Firefox, Safari, and Edge (specific minimum versions not separately tested)
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.2.1
Last Updated	2026-07-17
Validation	AI based check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy, nursing, and medical students learning the Cockcroft-Gault CrCl calculation
Healthcare educators teaching renal dosing methodology
Self-directed practice and review of weight-selection logic for drug dosing calculations

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams (as a sole resource)
Production use without expert validation
Pediatric patients, pregnant individuals, acute kidney injury, dialysis patients, or extreme body composition (BMI <15 or >40) — outside the validated population for this formula

Quality & Compliance

This tool includes 15 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all inputs stay on your device
Blocks accidental entry of sensitive information (SSN, phone numbers, emails, credit card numbers, medical record numbers, and long ID numbers)
Validates that entered values are within realistic physiological ranges

Reliability & Compatibility:

Compatible with modern versions of Chrome, Firefox, Safari, and Edge
Lightweight file (~101 KB) — opens instantly
Clear input labels throughout, with keyboard navigation support

Sources & Transparency:

Based on Cockcroft-Gault (1976), Devine IBW (1974), and KDIGO 2012/2024 GFR categories (versions stated in tool)
Sources cited within the tool, including PMID/DOI references
Assumptions displayed alongside every result
Clear unit labels throughout (mg/dL, µmol/L, kg, lbs, cm, in), with a warning about international unit differences
Version number and last-updated date shown in the tool

Scope & Limitations:

States which populations this tool covers (adults 18–92 with stable renal function) and which it excludes
Includes a warning about regional/institutional protocol differences
Shows specific examples of what NOT to use this tool for

Validation Process:

This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Provided "as-is" for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using CrCl Trainer, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get CrCl Trainer Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start practicing renal calculations offline.

Download The Tool

ExamFlow: Pharmacy Certification Study Calendar Tool (NAPLEX, BCPS, PTCB)

2026-07-28T17:31:37.104+00:00

ExamFlow

A study-calendar tool for pharmacy certification exam candidates.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

ExamFlow organizes exam-blueprint study topics into a personal calendar for candidates preparing for NAPLEX, BCPS, or PTCB certification. It is a scheduling and tracking tool — it does not teach content, test competency, or certify exam readiness.

After choosing an exam and a target date, the user builds a study calendar either by manually dragging individual topics onto specific days or by using the auto-generate function (choosing which days of the week to study and how many topics per day ). Each day can be opened to review its assigned topics and mark them complete. Topic lists are drawn from each exam's published blueprint (NABP for NAPLEX, BPS for BCPS, PTCB for PTCB), with source citations shown inside the tool.

Features & Functions

Three certification tracks to choose from — NAPLEX, BCPS, and PTCB — each with its own topic/domain blueprint
Live countdown showing days remaining until the selected exam date
Auto-generate function that distributes topics across chosen study days and a set number of topics per day
Manual drag-and-drop placement of individual topics onto any calendar day
Day view for reviewing a single day's assigned topics
Per-topic completion tracking (mark individual topics done / not done)
Progress panel showing overall and per-domain completion
Reference panel listing the source blueprint and guideline citations for each exam
Print/export function for the study calendar
Progress saves automatically in the browser and stays in sync across browser tabs open to the tool

How to Use This Tool

On the setup screen, choose your certification exam (NAPLEX, BCPS, or PTCB ) and enter your target exam date
The calendar view opens, showing a live countdown to your exam date
Either drag topics from the reference panel onto calendar days yourself, or click "Auto-Generate" to distribute them automatically across chosen study days
Click any day to view its assigned topics and mark individual ones complete
Track your overall and per-domain progress in the progress panel
Print or export your calendar at any time

Technical Specifications

Format	Single HTML file
File Size	~98 KB
Compatibility	Chrome, Firefox, Safari, Edge (modern versions)
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.3
Last Updated	April 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy students and candidates preparing for NAPLEX, BCPS, or PTCB certification
Self-directed candidates organizing study time against official exam-blueprint topics
Personal study planning and progress tracking

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams
Production use without expert validation
Teaching or explaining topic content — it schedules topics, it does not present or test the material itself

Quality & Compliance

This tool includes 13 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection required
No data collection — all progress is stored locally in your browser only
Zero external script or style dependencies
Detects and warns on accidental entry of sensitive information (email addresses, Social Security numbers, phone numbers) in the notes field

Reliability & Compatibility:

Works on modern browsers — Chrome, Firefox, Safari, Edge
Lightweight file (~98 KB) — opens instantly
Input validation with clear error messages (e.g., rejects invalid or past exam dates)

Sources & Transparency:

Version number and last-updated date shown in the tool
Source citations included and linked in-app (NABP, BPS, PTCB, ACC/AHA, USP, Surviving Sepsis Campaign)
States its own assumptions and scope limitations directly in the tool

Scope & Limitations:

States which exams and geographic region the content is scoped to, with a regional-variation warning
Lists specific examples of what not to use the tool for
Notes that content is fixed as of a stated date, with no automatic updates

Validation Process:

This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using ExamFlow, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get ExamFlow Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start organizing your study schedule offline.

Download The Tool

ShowDontTell: Pharmacy SIG Code to Patient Instruction Tool

2026-07-28T15:54:28.473+00:00

ShowDontTell — Patient Instruction Cards

A searchable reference tool that converts prescription SIG codes into plain-language, patient-ready instruction cards.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

This tool helps pharmacy professionals and pharmacy students turn prescription shorthand (SIG codes like "bid," "qhs," "prn" ) into simplified, plain-language instructions that can be shown or printed directly for a patient. It covers 34 common medication instructions across six categories: Timing, With/Without Food, Special Instructions, Route, Storage, and Safety. It is designed as a patient-counseling communication aid, not a source of clinical decision-making.

The user types a SIG code, an abbreviation, or a plain-language phrase into a search field (or taps one of ten quick-pick shortcuts). The tool matches the input against the SIG code list, the instruction title, and the instruction description at once, and displays the matching instruction card(s) for the user to select. The selected card can then be shown to the patient in a dedicated full-screen "Present Mode," or printed directly.

Features & Functions

Search matches on more than one field at once — the SIG abbreviation, the instruction title, and the instruction description, in the language currently selected.
Ten one-tap quick-pick shortcuts for the most common instructions (bid, tid, qid, qhs, prn, with food, do not crush, stay upright, avoid alcohol, refrigerate).
34 pre-written instruction cards across 6 categories (Timing, With/Without Food, Special Instructions, Route, Storage, Safety).
Save any instruction card to a personal favorites list, stored locally for quick access next time.
Full-screen "Show Patient" presentation mode, designed to be shown directly to a patient at the point of care.
Within Present Mode, step through multiple matching cards in sequence without leaving full-screen view.
Adjustable on-screen text size in the browse view — the selected size carries over automatically into Present Mode.
Full interface available in four languages (English, Spanish, Arabic, Chinese), including right-to-left layout for Arabic.
One-tap printing of the currently selected instruction card.
On-screen warning when a typed abbreviation has more than one recognized clinical meaning (e.g., "OD" can mean "once daily" or "right eye").

How to Use This Tool

Type a SIG code or plain-language phrase into the search box, or tap a quick-pick shortcut.
Select the matching instruction card from the results list on the left.
Review the patient-ready card shown on the right.
Tap "Show Patient" to display it full-screen for the patient, or "Print" to print it.
Optionally tap the star icon to save the card to your favorites list.
Switch the interface language or adjust text size at any time from the header controls.

Technical Specifications

Format	Single HTML file
File Size	~102 KB
Compatibility	Chrome, Firefox, Safari, Edge (current versions — not tested against specific version numbers )
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English, Spanish, Arabic, Chinese (interface)
Version	1.0.0
Last Updated	April 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy professionals and pharmacy staff preparing patient-ready medication instructions
Pharmacy and health-profession students learning patient counseling language
Reference during patient counseling or for printed take-home instructions

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams
Production use without expert validation
Pregnant or lactating patients (not validated for this population)
Pediatric use, unless a specific step explicitly says so
Acute illness or critical-care settings

Quality & Compliance

This tool includes 14 verified features:

Your Data & Privacy:

Works entirely offline — no internet connection needed
No external servers or third-party connections — nothing is transmitted anywhere
On-screen reminder not to enter patient names into the search field
Saved favorites are stored only in your browser and never leave your device

Reliability & Compatibility:

Works in current versions of Chrome, Firefox, Safari, and Edge
Lightweight file (~102 KB) — opens instantly, nothing to install
Keyboard-accessible interface with screen-reader labels on every interactive element

Sources & Transparency:

Version number and last-updated date shown directly in the tool
Clinical sources cited in the tool (USP <17>, ISMP 2024, AHRQ 3rd Ed.)

Scope & Limitations:

States which patient populations this tool does not cover (pregnant/lactating, pediatric unless noted, acute illness/critical care)
Includes a note on regional/local pharmacy standard variation
Shows specific examples of what not to use the tool for
Includes a fixed-content notice — this tool does not update automatically
Flags on-screen when a searched abbreviation has more than one recognized clinical meaning

Validation Process:

This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using ShowDontTell, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get ShowDontTell Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start converting SIG codes offline.

Download The Tool

StemMaster: Pharmacology Drug-Name Stems Flashcard Tool

2025-10-01T15:19:00.005+00:00

StemMaster

A flashcard, quiz, and reference tool for learning drug-name stem conventions used in pharmacology.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

StemMaster is an offline HTML tool for learning drug-name stem conventions — the suffixes and prefixes (such as -pril, -mab, -vastatin ) that indicate a drug's class or mechanism in pharmacology naming. It is designed for pharmacy, nursing, medical, and other health-science students studying drug nomenclature. It addresses the recurring study task of memorizing and recognizing stem-to-class relationships across a broad range of drug categories, rather than looking each one up individually.

The tool contains 109 drug-name stem entries organized into 9 categories (Cardiovascular, Infectious, Oncology, Neuro/Psych, Endocrine, GI, Respiratory, Immunology, and Misc/Other). Each entry lists the stem itself, its drug class, its mechanism, and example drug names. Users move between four modes — Flashcards, Quiz, Reference, and Progress — depending on whether they want to study, test themselves, look something up, or check how they're doing.

Features & Functions

Flashcard mode with a four-option self-rating system (Again / Hard / Good / Easy) after flipping each card
Cards you rate lower reappear more often on later passes; cards you rate highest are shown less often but still occasionally resurface for review
A streak counter tracks consecutive correct ratings/answers, with a separate best-streak record
Multiple-choice quiz mode with a running correct/wrong score
Search box matches on more than one field at once — you can type either a stem (e.g. "-pril") or an actual drug name (e.g. "lisinopril") and get the same result
Category filter chips let you narrow flashcards, quiz, or the reference table to one of the 9 categories, each showing a live count of entries
Reference mode: a full searchable table of all 109 entries, sortable by browsing category, with a print function for a paper copy
Progress mode: a per-category breakdown showing how many stems are reviewed, mastered, still need work, or not yet seen, with a mastery percentage bar for each category
Overall header stats: total stem count, current streak, and total mastered count, visible at all times
Keyboard shortcuts: Space or Enter to flip a flashcard, number keys 1–4 to rate it, arrow key to advance
Progress, ratings, and quiz scores are saved automatically between sessions on the same device
Flashcards and mode-switch buttons are keyboard-navigable and labeled for screen readers

How to Use This Tool

Open the HTML file in any browser — no installation or internet connection needed
On first open, read the disclaimer screen and click "I Understand" to continue
Start in Flashcards mode: read the stem side, click the card (or press Space/Enter ) to flip it, then rate yourself with Again / Hard / Good / Easy
Optionally narrow the deck first using the category chips at the top, or type a stem or drug name into the search box
Switch to Quiz mode to answer multiple-choice questions and track your correct/wrong score
Switch to Reference mode to search or browse the full table of entries, or click Print for a paper copy
Switch to Progress mode at any time to see your mastery breakdown by category
Progress is saved automatically — closing and reopening the file keeps your ratings, scores, and streak

Technical Specifications

Format	Single HTML file
File Size	~116 KB
Compatibility	Modern browsers (Chrome, Firefox, Safari, Edge) — built with standard web features; not version-tested individually
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.0
Last Updated	2026-07-15
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy, nursing, medical, and other health-science students studying drug-name nomenclature
Self-study and exam-practice supplementing (not replacing) coursework
Quick reference while reviewing drug classes

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams as sole preparation
Production use without expert validation
Dosing, interaction-checking, or any calculation-based task — the tool contains no calculators

Quality & Compliance

This tool includes 12 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all progress stays on your device (browser local storage)
Zero external dependencies — no fonts, scripts, or content loaded from the internet

Reliability & Compatibility:

Lightweight file (~116 KB) — opens instantly, no installation needed
Error handling for storage issues, with a clear on-screen message if progress can't be saved
Keyboard-accessible flashcards and labeled controls for screen readers

Sources & Transparency:

Version number and last-updated date shown in the tool
General data-source basis stated, with U.S.-specific regulatory notes flagged where they appear
States clearly that content is static and may not reflect the newest approvals or safety updates

Scope & Limitations:

States who the tool is designed for and what it does not cover
Flags that some regulatory notes are U.S.-specific and may not apply elsewhere
Includes specific examples of what NOT to use the tool for

Validation Process:

This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using StemMaster, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get StemMaster Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start mastering drug nomenclature offline.

Download The Tool

AbbrVault: Medical Writing & Clinical Abbreviation Reference Tool

2025-10-01T14:46:00.004+00:00

AbbrVault — Medical Writing Reference

An offline reference tool for pharmaceutical and medical abbreviations, with an automatic flag for terms ISMP designates as error-prone.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

AbbrVault is a searchable reference library of pharmaceutical and medical abbreviations, built for people who need to look up or standardize terminology while drafting clinical, regulatory, or academic documents. It addresses the problem of inconsistent, ambiguous, or unsafe abbreviation use by combining a searchable library with an automatic flag for abbreviations that ISMP designates as error-prone or "Do Not Use."

The library contains 725 entries across 15 subject categories — including routes of administration, dosing frequency, dosage forms, statistics, regulatory/ICH terminology, adverse events, laboratory values, and pharmacokinetics — compiled from terminology used by ICH, FDA, EMA, ISMP (both the U.S. and Canada lists ), MedDRA, and CDISC. The user searches or browses the library, adds relevant entries to a personal document list (which can include their own custom entries), and exports the finished list as plain text, Markdown, an HTML table, or a Word-pasteable format.

Features & Functions

Searchable library of 725 pharmaceutical/medical abbreviation entries
Search matches against both the abbreviation itself and its full expansion/definition in the same search box
15 subject-matter categories to filter by (Routes of Administration, Dosing Frequency, Dosage Forms, Study Design, Statistics, Regulatory/ICH, Adverse Events, Laboratory, Pharmacokinetics, Vital Signs & Physical, Time & Duration, Organizations, Document Types, Clinical Terms, Miscellaneous), plus an "All Abbreviations" view
Automatic visual flag (badge and colored border) on any entry ISMP designates as "Do Not Use" or error-prone
Build a personal, ordered document list by adding entries from the library
Add custom abbreviation entries of your own alongside the built-in library
Custom entries are automatically screened for common sensitive-data patterns before being added
Sort your document list three ways: order added, alphabetically, or grouped by category
Reorder your document list by dragging entries (available in "order added" mode)
Remove individual entries from your document list, or clear all custom entries at once
Export your document list in four formats: plain text, Markdown, an HTML table, or tab-separated (Word-pasteable)
Copy the export directly to your clipboard, with an automatic fallback method if the browser blocks the standard copy action
Download the export as a file
Print your document list directly from the browser
Your document list and custom entries are saved automatically in your browser and persist between sessions on the same device

How to Use This Tool

Type a term into the search box, or browse by selecting a category from the sidebar
Review the results — entries ISMP flags as "Do Not Use" or error-prone are marked with a warning badge
Click the "+" button on any entry to add it to your document list
Optionally, add your own terms using the "Add Custom Entry" form
Sort your document list by order added, alphabetically, or by category, and drag to reorder when needed
Open the export panel and choose a format: plain text, Markdown, HTML table, or Word-tabbed
Copy, download, or print the finished list

Technical Specifications

Format	Single HTML file
File Size	~115 KB
Compatibility	Tested on a current version of Chrome. Expected to work on recent versions of Firefox, Safari, and Edge based on standard web features used (not separately tested )
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.1
Last Updated	July 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Medical writers and regulatory affairs professionals drafting clinical or regulatory documents
Pharmacy, nursing, and medical students learning standard pharmaceutical/medical abbreviations
Clinical research coordinators compiling a document-specific abbreviation list

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams
Production use in real patient records, prescriptions, or medication orders without expert validation
Use as your institution's official, exhaustive abbreviation policy — the tool itself states it is not a comprehensive list

Quality & Compliance

This tool includes 11 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all data stays in your browser's local storage on your device
Blocks accidental entry of sensitive information (SSNs, phone numbers, credit card numbers, email addresses, medical record/patient ID numbers, long numeric IDs) when adding custom entries

Reliability & Compatibility:

Tested on a current version of Chrome; expected to work on recent Firefox, Safari, and Edge versions (not separately tested)
Single file, ~115 KB — opens instantly, no installation

Sources & Transparency:

Version number and last-updated date shown in the tool itself
Sources cited within the tool (ICH, FDA, EMA, ISMP — both the U.S. and Canada lists — MedDRA, CDISC)

Scope & Limitations:

States specific exclusions for what this tool should not be used for (e.g., an active patient's medical record, prescription, or medication order)
Includes a warning that ISMP designations and terminology vary by country and institution
Shows specific examples of what not to use this tool for
States that the reference content is static and when it was last reviewed

Validation Process:

This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using AbbrVault, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get AbbrVault Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start building your reference lists offline.

Download The Tool

CaCorrect: Albumin-Adjusted Calcium Calculator & Quiz Tool

2025-10-01T12:31:00.005+00:00

CaCorrect

A single-file HTML tool for calculating and practicing albumin-adjusted (corrected) serum calcium using the Payne 1973 formula.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

CaCorrect is an offline educational tool for calculating and practicing corrected calcium interpretation using the Payne 1973 albumin-adjustment formula. It is intended for healthcare students and professionals learning to interpret total calcium results in the context of abnormal serum albumin, and covers the calculation itself, its result categories, and practice against a set of scenarios.

The tool provides three modes: a calculator, a set of practice cases, and a quiz mode. In the calculator, the user enters a measured total calcium value and a serum albumin value; the tool applies the Payne 1973 formula (Corrected Ca = Measured Ca + 0.8 × [4.0 − Albumin] ) and returns the corrected value along with a classification (Hypocalcemia, Normal, or Hypercalcemia) based on an 8.5–10.5 mg/dL reference range. The Practice Cases and Quiz Mode present 25 fictional scenarios covering a range of conditions (e.g., malnutrition, chronic kidney disease, malignancy, pregnancy) for the user to work through using the same formula.

Features & Functions

Corrected calcium calculator using the Payne 1973 albumin-adjustment formula
Automatic classification of the corrected result as Hypocalcemia, Normal, or Hypercalcemia
Calculation assumptions displayed alongside every result
Unit-conversion note for calcium (mg/dL vs. mmol/L)
"Copy Result" button that copies the corrected value, inputs, and formula reference as text
25 fictional practice case scenarios spanning a range of conditions and calcium/albumin combinations
"Random Case" button that loads one practice case at a time
"Show All Cases" button that loads all 25 practice cases at once
Quiz Mode that presents a case and asks the user to calculate the corrected value and select its category
Quiz progress tracking: rolling percentage correct (last 10 answers), a running "X of Y correct" count, and a streak counter
Detection and blocking of apparent real patient identifiers entered into the calculator (e.g., SSN-like numbers, email addresses, credit-card-like numbers, medical record numbers)
Range checks that reject calcium or albumin entries outside realistic physiological limits, with an explanatory message
Keyboard navigation between the three modes (arrow keys)

How to Use This Tool

Open the file in a web browser — no installation or internet connection required.
Read and acknowledge the introductory notice to access the tool.
On the Calculator tab, enter a measured calcium value and an albumin value, then select "Calculate" to see the corrected value, its category, and the assumptions used.
Optionally select "Copy Result" to copy the result as text, or "Reset" to clear the fields.
On the Practice Cases tab, select "Random Case" to work through one scenario at a time, or "Show All Cases" to view all 25 at once.
On the Quiz Mode tab, review the case shown, enter your calculated value and select a category, then select "Submit Answer" to see feedback and updated progress.

Technical Specifications

Format	Single HTML file
File Size	~72 KB
Compatibility	Expected to work on current versions of Chrome, Firefox, Safari, and Edge
Internet Required	No (works 100% offline )
Installation	None — open file in any browser
Language	English
Version	1.1
Last Updated	July 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Healthcare students learning to interpret calcium results in the context of abnormal albumin
Nursing, pharmacy, and allied health professionals reviewing or practicing corrected calcium calculations
Self-study or supplementary coursework practice

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams
Production use without expert validation
Patients with CKD Stage 4–5/ESRD/dialysis, critical illness with acid-base disturbances, paraproteinemia (e.g., multiple myeloma), pregnancy, or pediatric patients — the formula is particularly unreliable in these populations

Quality & Compliance

This tool includes 14 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — nothing is sent over the network or stored outside your current browser session
Blocks apparent real patient identifiers from being entered (e.g., SSN-like numbers, emails, credit-card-like numbers, medical record numbers)
Validates that entered calcium and albumin values are within realistic physiological ranges

Reliability & Compatibility:

Expected to work on current versions of Chrome, Firefox, Safari, and Edge
Lightweight file (~72 KB) — opens instantly
Error messages shown directly next to the relevant input field

Sources & Transparency:

Based on the Payne 1973 albumin-adjusted calcium formula (version and year stated in the tool)
Formula and reference-range sources cited within the tool, including a "Current Evidence" note on more recent research questioning the formula's reliability
Assumptions used in each calculation displayed alongside the result
Clear unit labels throughout (mg/dL, g/dL), with a conversion note for mmol/L

Scope & Limitations:

States the population this tool is traditionally applied to, and the populations it is particularly unreliable for
Includes a warning that reference ranges are US-based and may vary by country/laboratory
Shows specific examples of what NOT to use this tool for

Validation Process:

This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using CaCorrect, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get CaCorrect Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start practicing offline.

Download The Tool

RxDecoder QuizMaster: Pharmacy Abbreviations Flashcard Tool

2025-10-01T12:21:00.004+00:00

RxDecoder QuizMaster

A pharmacy abbreviation reference and self-testing tool covering 210 clinical abbreviations.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

RxDecoder QuizMaster is a study tool for recognizing and understanding pharmacy and clinical abbreviations. It is built for pharmacy, nursing, and allied-health students, and for practicing professionals who want to review or refresh their knowledge of prescription shorthand. It addresses a specific, well-documented patient-safety problem: many common clinical abbreviations are ambiguous or easily misread, and error-prone abbreviations are a recognized contributor to medication errors.

The tool presents one abbreviation at a time as a flashcard; the user reveals its meaning, then self-rates their recall. Content covers frequency/dosing shorthand (e.g., qd, bid, tid ), routes of administration, timing and meal-related instructions, Latin prescription terms, measurement units, dispensing terms, and general clinical abbreviations. Abbreviations are drawn primarily from US clinical standards (ASHP, ISMP, Ansel's) and Joint Commission guidance, cross-checked against the ISMP 2024 List of Error-Prone Abbreviations, with high-alert entries visibly flagged.

Features & Functions

Flashcard quiz covering 210 pharmacy/clinical abbreviations, presented one at a time
Weighted review ordering — previously missed cards are about 4x more likely to come up early in a session, and "almost" cards about 2x, so weaker terms resurface sooner (each session is still randomized, not a fixed order)
Three-way self-rating per card (Missed / Almost / Got It) that feeds the weighting above
Live session stats bar tracking streak, known, unsure, and missed counts
Category filtering across 7 groups: Frequency, Route, Timing, Latin, Measures, Dispense, Misc
Dedicated Search mode that matches a query against the abbreviation itself, its short meaning, and its full explanation text in a single search
Weak Spots mode — automatically builds a review list of every card previously missed or marked unsure, ranked by how often each was missed
One-click "Practice" button to drill a single card directly from the Weak Spots list
ISMP warning badges (⚠) shown on abbreviations flagged as error-prone, visible on both the flashcard and in search results
Status dot shown next to each result in Search mode, color-coded to whether you've previously marked that card known, unsure, or missed
Printable summary sheet via a dedicated Print Sheet button, with output that reflects your current category filter
Session progress (streak, known/unsure/missed counts, per-card history) is saved automatically in your browser and restored the next time you open the tool
One-click "Reset Session" to clear saved progress and start over
Keyboard shortcuts — Space to flip the active card, 1/2/3 to rate it Missed/Almost/Got It

How to Use This Tool

Open the HTML file in a web browser — no installation needed
Read the introductory disclaimer screen, shown on first use
Choose a mode: Quiz Me, Search, or Weak Spots
In Quiz Me, optionally filter by category, then click the card or press Space to reveal its meaning
Rate the card Missed, Almost, or Got It — your rating adjusts how soon that card reappears
Switch to Search at any time to look up a specific abbreviation directly
Visit Weak Spots to review only the cards you've previously missed or marked unsure, ranked by difficulty, or tap Practice on any single card
Use Print Sheet to generate a printable version of the current filtered list
Progress saves automatically as you go; use Reset Session at any time to start fresh

Technical Specifications

Format	Single HTML file
File Size	~100 KB
Compatibility	Current versions of Chrome, Firefox, Safari, and Edge (specific minimum versions not independently tested )
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	3.6
Last Updated	June 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy, nursing, and allied-health students learning to recognize clinical abbreviations
Practicing healthcare professionals reviewing or refreshing abbreviation knowledge
Self-directed study and repeated quiz-style review

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exam preparation (supplementary use only, not a substitute for accredited training)
Production or institutional use without expert validation
Serving as an official institutional reference or a record of any specific facility's approved abbreviation policy

Quality & Compliance

This tool includes 12 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all progress stays on your device (browser local storage only)
Zero external dependencies — no fonts or scripts loaded from the internet

Reliability & Compatibility:

Works in current versions of Chrome, Firefox, Safari, and Edge
Lightweight file (~100 KB) — opens instantly
Handles storage errors gracefully — a failed save won't crash the tool

Sources & Transparency:

Version and last-updated date shown in the tool (Version 3.6, June 2026)
Sources cited: ASHP, ISMP, Ansel's, and Joint Commission guidance, cross-checked against the ISMP 2024 List of Error-Prone Abbreviations
States that abbreviation standards and prohibited-abbreviation lists vary by country and institution

Scope & Limitations:

States who the tool is built for and what it doesn't replace
Lists specific examples of what not to use this tool for
Static-content notice — content is fixed as of the listed date, with no automatic updates

Validation Process:

This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using RxDecoder QuizMaster, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get RxDecoder QuizMaster Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start practicing offline.

Download The Tool

StorageSmart: Pharmacy Inventory & Storage Trainer Tool

2025-09-27T23:39:00.012+00:00

StorageSmart — Pharmacy Inventory Trainer

An interactive quiz, searchable reference table, and progress tracker for pharmacy storage and handling classification of 188 real branded medications.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

StorageSmart is an educational tool for practicing correct storage and handling classification of real branded medications across 8 categories: Refrigerated, Frozen, Controlled Substance, Hazardous Drug, Flammable, Light-Sensitive, Protect from Moisture, and Room Temperature. It is designed for pharmacy students, technicians, and pharmacists who want to build or test their recall of storage requirements — including DEA controlled-substance scheduling and USP <800> hazardous-drug handling — for real, named products rather than generic categories.

The tool has three modes. In Quiz mode, a drug card is shown and the user selects its correct storage category from four options; the tool gives immediate feedback plus the specific handling rule for that drug. In Reference mode, the same 188-drug database can be searched (matching brand name, generic name, drug class, or the handling-rule text itself ) or filtered by storage category, and viewed as a table. In Progress mode, mastery is tracked per storage category based on quiz performance, stored locally in the browser.

Features & Functions

Interactive quiz covering 188 real branded medications across 8 storage/handling categories
Immediate answer feedback showing the correct category and the drug's specific handling rule
Category filter — quiz and reference view can both be restricted to a single storage category (e.g., practice only Controlled Substances)
Reference table search that matches four fields at once: brand name, generic name, drug class, and the handling-rule text — not just the drug name
Searchable, filterable reference table showing all matching drugs with their storage category, generic name/class, and handling rule
Printable "Cheat Sheet" — exports the full reference table to a print-formatted view
Per-category progress tracking (mastery by storage category), stored locally in your browser
Running session stats: correct answers, incorrect answers, and current streak
One-click progress reset (with confirmation prompt) to start tracking over
Storage categories cross-reference DEA controlled-substance scheduling (Schedule II–V) and USP <800> hazardous-drug handling classifications, stated explicitly per drug where applicable
Keyboard shortcuts in Quiz mode — number keys (1-4) to answer, Space/Enter to continue to the next drug
Works entirely offline — no internet connection required after the file is opened
No data leaves your device — all progress/stats stay in local browser storage only

How to Use This Tool

Open the HTML file in any modern browser — no installation needed
Read and acknowledge the initial disclaimer screen (shown once per version )
Choose a mode from the top bar: Quiz, Reference, or Progress
In Quiz mode: read the drug shown, select its correct storage category from the four options, review the feedback and handling rule, then continue to the next drug
Optional: use the category filter to focus the quiz on one storage category at a time
In Reference mode: type in the search box (matches brand, generic, class, or rule text) and/or use the category filter to narrow the table
In Reference mode: select "Cheat Sheet" to open a print-formatted version of the current table
In Progress mode: review mastery by category, or select "Reset Progress" to clear all tracked stats

Technical Specifications

Format	Single HTML file
File Size	~221 KB
Compatibility	Chrome 90+, Firefox 88+, Safari 14+, Edge 90+
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.0
Last Updated	2026-07-22
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmacy students building recall of storage/handling classification
Pharmacy technicians and pharmacists using it as a self-study or refresher reference
Personal practice, review, or continuing-education support

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exam preparation as a sole resource
Production use (e.g., as an actual pharmacy SOP or inventory reference) without expert validation
Practice settings outside the United States (content is based on US frameworks — DEA scheduling, USP <800>)

Quality & Compliance

This tool includes 11 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all progress and stats stay on your device
Zero external dependencies — no CDN or third-party resources loaded

Reliability & Compatibility:

Uses standard, long-supported web technology — no specialized browser or plugin required
Lightweight file (~221 KB)
Keyboard shortcuts available for answering quiz questions

Sources & Transparency:

Sources cited for storage/handling classifications (DEA scheduling, USP <800>)
Version and last-updated date stated in the tool

Scope & Limitations:

States which audience the tool is designed for and what it is not designed for
Includes a warning about regional (US-specific) standard differences
Shows specific examples of what NOT to use this tool for

Validation Process:

This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using StorageSmart, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get StorageSmart Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start practicing offline.

Download The Tool

RolePlay Pro: Pharma Sales Objection Simulator Tool

2025-09-26T19:11:00.011+00:00

RolePlay Pro — Pharma Objection Simulator

A single-file HTML tool for practicing pharmaceutical sales objection-handling through roleplay scenarios.

⚠️ AI-built tool — human expert review required before real-world use.

What This Tool Does

RolePlay Pro presents pharmaceutical sales representatives with simulated physician objections drawn from 23 scenarios across 10 therapeutic areas (Cardiovascular, Oncology, Diabetes & Metabolic, CNS/Neurology, Respiratory, Immunology/Rheumatology, Infectious Disease, Gastroenterology, Pain Management, Dermatology ), each tagged Easy, Medium, or Hard. Each scenario presents a fictional HCP profile and a specific objection for the user to practice responding to.

After the user formulates their own response, the tool reveals a model response broken into an Acknowledge / Bridge / Resolve structure, referencing named clinical trials, published guidelines, and drug mechanisms relevant to the objection. The user self-rates their own response as "Strong" or "Needs Work," and can add free-text coaching notes to each session-log entry. Users can also filter scenarios by therapeutic area or difficulty, create their own custom objection-and-response pairs, and print a scenario/response sheet for offline reference.

Features & Functions

23 pre-built objection-handling scenarios across 10 therapeutic areas
Three difficulty levels (Easy, Medium, Hard) plus an "All" view
Filter scenarios by therapeutic area, by difficulty, or both combined
Model responses structured as Acknowledge / Bridge / Resolve
Self-rating on each completed scenario ("Strong Response" / "Needs Work")
Free-text coaching notes field attached to each session-log entry
Running session tally of total scenarios, "Strong," and "Needs Work" counts, saved between visits
Create custom objection-and-response scenarios with your own therapeutic area and HCP name
Quick-add option to log a real objection you heard, tagged to a therapeutic area, without writing a full model response
Separate reset controls for the session log and for custom scenarios
Print function that formats the current scenario and its response for a printed page
Keyboard shortcuts: Space to reveal a response or advance, Right Arrow to advance, R to reveal, Escape to close an open dialog
Blocks saving a custom scenario whose text appears to contain an email address, phone number, credit card number, Social Security Number, or medical record number, with a warning before it's stored
Repeat-avoidance so recently shown scenarios are less likely to repeat immediately in a row

How to Use This Tool

Open the file in a browser — no installation needed
Select a therapeutic area from the left panel, or leave it on "All"
Choose a difficulty level (Easy, Medium, Hard, or All ) from the top bar
Click "New Scenario" to display an objection from a simulated HCP
Formulate your own response, then reveal the model response to compare
Rate your own response as "Strong Response" or "Needs Work"
Optionally add a coaching note in the session log for that entry
Click "Skip" to move to a new scenario without rating the current one
Use "+ Custom" to add your own objection and response, or "Quick Add" in the log panel for a fast entry
Use "🖨 Print" to print the current scenario and response
Use "↺ Reset Log" or "↺ Reset Custom" to clear session history or custom scenarios separately

Technical Specifications

Format	Single HTML file
File Size	~114 KB
Compatibility	Tested in Chrome/Edge 90+; expected to work in Firefox 88+ and Safari 14+, not separately verified
Internet Required	No (works 100% offline)
Installation	None — open file in any browser
Language	English
Version	1.3
Last Updated	July 2026
Validation	AI based Check-and-fix cycles — expert review required
Status	AI-generated educational prototype

Who Should Use This

Designed For:

Pharmaceutical sales representatives practicing objection-handling dialogue
Sales training or L&D use for onboarding or ongoing practice
Self-paced rehearsal of physician conversations before a real call

NOT Designed For:

Clinical decision-making or patient care
Professional certification or licensing exams
Production or promotional use without expert validation
Real, identifiable physician or patient information — the tool's own scenario fields are meant for fictional names and generic situations only

Quality & Compliance

This tool includes 12 verified features:

Your Data & Privacy:

Works 100% offline — no internet connection needed
No data collection — all data stays on your device
Blocks accidental entry of sensitive information (email addresses, phone numbers, credit card numbers, Social Security Numbers, medical record numbers) in custom scenario fields, with a warning before saving
Zero external dependencies — no CDN or third-party script calls

Reliability & Compatibility:

Directly tested in Chrome and Edge 90+; expected (not separately verified) to work in Firefox 88+ and Safari 14+
Lightweight file (~114 KB) — opens instantly
Keyboard-operable scenario navigation (Space, Right Arrow, R, Escape)

Sources & Transparency:

Scenario dialogue references named clinical trials and published society guidelines
Version and last-updated date displayed in the tool
Full disclaimer text available on demand from within the tool

Scope & Limitations:

States what the tool does not do (medical advice, diagnosis, treatment recommendations, dosing, patient-specific guidance)
Includes examples of what not to use the tool for
States that content is fixed with no automatic updates, and that currency should be independently verified

Validation Process:

This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.

License Terms

Allowed:

Personal educational use
Internal training within your organization
Academic coursework and self-study

Not Allowed:

Production or operational use without expert validation
Redistribution or resale (unless Commercial Resale License purchased)
Clinical decision-making for patient care
Removing or modifying disclaimers

Our Fair Price Philosophy

Your Feedback Matters

We are constantly working to improve our tools. After using RolePlay Pro, we would be grateful if you could share your thoughts on its functionality and usefulness.

✉️ Send Us Your Feedback

Get RolePlay Pro Today

$7+

(Suggested Price: $7 - $13 | Pay What's Fair)

Download the single HTML file instantly and start practicing offline.

Download The Tool

DrugPamphlet: Egyptian Drug Guide & Commentaries

Neonatal Herpes Simplex Virus (HSV): Interactive Clinical Study Tool

Neonatal HSV Infection: Interactive Study Station

Congenital Cytomegalovirus (CMV): Interactive Clinical Study Tool

Cutis Marmorata Telangiectatica Congenita (CMTC): Interactive Clinical Study Tool

Cutis Marmorata Telangiectatica Congenita CMTC

What is CMTC?

Normal newborn mottling or CMTC?

What does CMTC look like?

What causes CMTC?

What else should we look for?

How is CMTC diagnosed?

What else could it be?

How is CMTC managed?

What is the long-term outlook?

Identity

vs Physiological

Look

Where

Cause

Associations

Criteria

Tests

Mimics

Manage

Outlook

Sources

Aplasia Cutis Congenita (ACC): Interactive Clinical Study Tool

Aplasia Cutis Congenita (ACC) — Interactive Study Engine

Q1: What is Aplasia Cutis Congenita (ACC) & What tissue layers can be missing?

Q2: How common is ACC & Why do published incidence numbers differ?

Q3: What causes ACC in utero? (6 Proposed Mechanisms)

Q4: How does ACC look clinically & What red-flag signs matter?

Q5: When is imaging required & When is biopsy forbidden?

Q6: Conservative vs. Surgical Care & What is the Prognosis?

Active Cloze Recall — Select the Correct Bracketed Term, Then Verify

1. The 3 Major ACC Syndromes — Side-by-Side De-angler

2. Differential Diagnosis (7 Look-Alikes to Distinguish from ACC)

Frieden Classification (1986) — Types I to IX Master Reference & Self-Test

⚡ Quick Fire: High-Risk Numbers & Eponyms Check

Clinical Categorization Sorter — Click an Item, Then Click Its Correct Group

Active-Recall Flashcards (Spaced Queue)

Clinical Board-Style MCQ Exam

Exam-Eve Ultra-Rapid Keyword Sheet (60-Second Scan)

1. Core Numbers & Sites

2. Red Flags & Contraindications

3. Teratogens & Infections (Type VIII)

4. Syndrome Triad Summary

Miliaria (Heat Rash): Interactive Clinical Study & Mastery Tool

Miliaria Crystallina & Miliaria Rubra

Q1What is miliaria?

Q2Where is the block? — the difference that explains everything

Q3How does each one look and feel?

Q4Who gets it, and when?

Q5Why does it happen?

Q6How is it diagnosed?

Q7What can look like it? — clue → think

Q8How is it treated?

Q9Complications and prognosis

Q10When to seek medical assessment

2Fill-in: pick the right word in the brackets

3Flashcards

4Multiple-choice quiz

5aHard bits: numbers, sizes, sites

5bSequence: tap the steps in order

6Sort: MC, MR, or both?

7Night-before review

MC

MR

Variants

Causes · SOLID

Diagnosis

Look-alikes

Treat

Red flags

Seborrheic Dermatitis: High-Yield Interactive Clinical Study Tool

Q1What exactly is seborrheic dermatitis?

Q2Who gets it, and how does it behave over time?

Q3Why does it happen?

Q4Where does it appear, and what does each site look like?